Item Name	Item ID	Requesting PI	Order Date	Institution	Country
Anti-PSD-95 [K28/43] (Recombinant Antibody)	196561-rAb	Fredrik Sterky	4/20/2023	Goteborgs Universitet	SE
LRP4 (extracellular) scFv [N207/27]	190537	Yihe Huang	4/19/2023	University of Nebraska at Lincoln	US
Nav1.7 Na+ channel scFv [N68/6]	182094	Paul Miller	4/19/2023	University of Cambridge	GB
Anti-HCN1 [N70/28R] (Recombinant Antibody trial size)	180092-rAb.T	Kang-Sik Park	4/19/2023	Kyung Hee University	KR
Anti-HCN2 [N71/37R] (Recombinant Antibody trial size)	184178-rAb.T	Kang-Sik Park	4/19/2023	Kyung Hee University	KR
Anti-Nav1.8 Na+ channel [N134/12R] (Recombinant Antibody)	192035-rAb	Aubin Moutal	4/17/2023	Saint Louis University	US
Anti-GFP [N86/38.1R]	114492	N. Tonks	4/14/2023	Cold Spring Harbor Laboratory	US
Anti-GluN2B [N59/20R]	177565	Katharina Schmack	4/14/2023	Francis Crick Institute	GB
Anti-GluN2C [N422/18R]	177551	Katharina Schmack	4/14/2023	Francis Crick Institute	GB
Anti-GluN2A [N327A/38R]	177532	Katharina Schmack	4/14/2023	Francis Crick Institute	GB
Anti-GluN2A [N327/95R]	177531	Katharina Schmack	4/14/2023	Francis Crick Institute	GB
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Katharina Schmack	4/14/2023	Francis Crick Institute	GB
Anti-GFP [N86/8R]	177572	Masahiro Shiokawa	4/13/2023	Kyoto University, Graduate School of Medicine	JP
Anti-TrpC5 [N67/15R]	182118	Edward Yu	4/13/2023	Case Western Reserve University	US
TrpC5 scFv [N67/15]	190564	Edward Yu	4/13/2023	Case Western Reserve University	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	Ian Hogue	4/12/2023	Arizona State University	US
Anti-Neurexin-1-Beta [N170A/1.1R] (Recombinant Antibody)	180100-rAb	Ian Hogue	4/12/2023	Arizona State University	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Dynlacht	4/10/2023	New York University School of Medicine	US
Anti-Cav3.2 Ca2+ channel [N55/10R] (Recombinant Antibody)	184196-rAb	Yumiko Yoshimura	4/10/2023	National Institute for Physiological Sciences	JP
Anti-GFP [N86/38.1R]	114492	Graham Dellaire	4/7/2023	Dalhousie University	CA
Anti-Neurexin-1-Beta [N170A/1.1R] (Recombinant Antibody trial size)	180100-rAb.T	Akihiro Harada	4/7/2023	Osaka University	JP
Anti-GFP [N86/38.1R]	114492	Andrew Osborne	4/5/2023	University College London	GB
Anti-BAF53b [N332B/15R] (Recombinant Antibody)	184200-rAb	Jacek Jaworski	4/5/2023	International Institute of Molecular and Cell Biology (IIMCB)	PL
Anti-NSD1 [N312/10] (Recombinant Antibody)	192041-rAb	Jia-Ray Yu	4/4/2023	Virginia Polytechnic Institute and State University	US
Anti-NSD1 [N312/10] (Recombinant Antibody)	192041-rAb	Jia-Ray Yu	4/4/2023	Virginia Polytechnic Institute and State University	US
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R] (Recombinant Antibody)	180102-rAb	Steven Paul Jones	4/3/2023	University of Louisville	US
Anti-GFP [N86/38.1R]	114492	Hongbo Zhou	4/2/2023	Huazhong Agricultural University	CN
Anti-6xHis [N144/14R]	177500	Hongbo Zhou	4/2/2023	Huazhong Agricultural University	CN
Anti-PINK1 [N4/15R]	177546	Angelika Harbauer	3/31/2023	Max Planck Institute for Biological Intelligence	DE
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Michael Salling	3/30/2023	Louisiana State University Health Sciences Center, New Orleans	US
IRSp53/BAIAP2 scFv [L117/1]	190506	Dr Vanessa D'Costa	3/30/2023	University of Ottawa	CA
Anti-Calbindin [L109/57R]	177455	Mingjie Zhang	3/30/2023	Hong Kong University of Science and Technology	HK
Anti-mGluR1/5 (Group I) glutamate receptor [N75/3R]	182119	Mingjie Zhang	3/30/2023	Hong Kong University of Science and Technology	HK
Anti-Dopamine D2 receptor [N186/29R]	177509	Mingjie Zhang	3/30/2023	Hong Kong University of Science and Technology	HK
Anti-Dopamine D3 receptor [N331/19R]	114488	Mingjie Zhang	3/30/2023	Hong Kong University of Science and Technology	HK
Anti-ADAM22 (cytoplasmic) [N46/30R]	177555	Mingjie Zhang	3/30/2023	Hong Kong University of Science and Technology	HK
Anti-Olig1 [N149/25.1R] (Recombinant Antibody trial size)	180103-rAb.T	Kristopher Sarosiek	3/29/2023	Harvard School of Public Health	US
Anti-GFAP [N206A/8R] (Recombinant Antibody trial size)	193445-rAb.T	Kristopher Sarosiek	3/29/2023	Harvard School of Public Health	US
VGlut2 scFv [N29/29]	182085	Charlotte Boccara	3/29/2023	University of Oslo, Centre for Molecular Medicine Norway (NCMM)	NO
Anti-TrpM7 [N74/25R]	177569	Roderick MacKinnon	3/28/2023	Rockefeller University	US
Anti-GFP [N86/38.1R]	114492	Prof.Frank Caruso	3/28/2023	University of Melbourne	AU
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R] (Recombinant Antibody trial size)	182998-rAb.T	Gaurav Varshney	3/27/2023	Oklahoma Medical Research Foundation	US
Anti-GFP [N86/38.1R]	114492	FRANCISCO JAVIER DIEZ GUERRA	3/27/2023	Centro de Biologia Molecular Severo Ochoa	ES
Anti-Cav3.2 Ca2+ channel [N55/10R] (Recombinant Antibody)	184196-rAb	Jean-Ju Chung	3/25/2023	Yale University	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody trial size)	180085-rAb.T	Adriano Aguzzi	3/24/2023	Zurich University Hospital	CH
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Peter Scheiffele	3/24/2023	University of Basel	CH
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Peter Scheiffele	3/24/2023	University of Basel	CH
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Peter Scheiffele	3/24/2023	University of Basel	CH
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Peter Scheiffele	3/24/2023	University of Basel	CH
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Elizabeth Tarling	3/23/2023	University of California, Los Angeles (UCLA)	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Isabelle Arnal	3/23/2023	Universite Grenoble Alpes	FR
Anti-Pan-FHF-A [N235/22R] (Recombinant Antibody)	190888-rAb	Geoffrey Pitt	3/22/2023	Cornell University, Weill Medical College	US
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R] (Recombinant Antibody trial size)	180102-rAb.T	Gaurav Varshney	3/21/2023	Oklahoma Medical Research Foundation	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Alexis Jourdain	3/16/2023	Universite de Lausanne (UNIL)	CH
Anti-GFP [N86/8R] (Recombinant Antibody)	184171-rAb	Alexis Jourdain	3/16/2023	Universite de Lausanne (UNIL)	CH
C-Fos scFv [N486/32]	182090	Hiroyuki Hioki	3/16/2023	Juntendo University	JP
c-Fos scFv [N486/76]	190560	Hiroyuki Hioki	3/16/2023	Juntendo University	JP
Anti-Pan-Nav1 Na+ channel [N419/78R]	114553	Nitima Suttipanta	3/16/2023	Ubon Ratchathani University	TH
Anti-GFP [N86/38.1R]	114492	NURI OZTURK	3/16/2023	Gebze Technical University	TR
Anti-6xHis [N144/14R] (Recombinant Antibody)	184180-rAb	Hong Wanjin	3/15/2023	Institute of Molecular and Cell Biology, A*STAR Research Entities	SG
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Hong Wanjin	3/15/2023	Institute of Molecular and Cell Biology, A*STAR Research Entities	SG
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Andrew Carter	3/14/2023	MRC Laboratory of Molecular Biology	GB
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Andrew Carter	3/14/2023	MRC Laboratory of Molecular Biology	GB
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Esther H. Chang	3/13/2023	Georgetown University	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Esther H. Chang	3/13/2023	Georgetown University	US
Anti-GST [N100/13R ]	188214	shizhi Wang	3/13/2023	Southeast University	CN
Anti-TrpV3 [N15/4R] (Recombinant Antibody)	184212-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Calbindin [L109/57R] (Recombinant Antibody)	193442-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-GFP [N86/8R] (Recombinant Antibody)	184171-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-nNOS/NOS1 [L121/25R] (Recombinant Antibody)	193444-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Kv1.6 K+ channel [K19/36R] (Recombinant Antibody)	184211-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Fig4/Sac3 [N202/7R] (Recombinant Antibody)	192037-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Botch [N116/14R] (Recombinant Antibody)	191818-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-GFP [N86/38] (Recombinant Antibody)	196560-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-HCN2 [N71/37R] (Recombinant Antibody)	184178-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Calretinin [L122/6R] (Recombinant Antibody)	193446-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Parvalbumin [L114/81R] (Recombinant Antibody)	193440-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-NSD1 [N312/10] (Recombinant Antibody)	192041-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Thorase/Atad1 [N125/10R] (Recombinant Antibody)	184207-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-GFAP [N206A/8R] (Recombinant Antibody)	193445-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Ankyrin-G [N106/36] (Recombinant Antibody)	192039-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-TrpC5 [N67/15R] (Recombinant Antibody)	184205-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Neuregulin-CRD [N126B/31R] (Recombinant Antibody)	191808-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Kvbeta1.1/KCNAB1 K+ channel [K9/40R] (Recombinant Antibody)	190892-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Brevican [N294A/10R] (Recombinant Antibody)	190891-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-LRRTM4 [N205B/22R] (Recombinant Antibody)	190889-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Pan-FHF-A [N235/22R] (Recombinant Antibody)	190888-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Pan-KChIP K+ channel [K55/82R] (Recombinant Antibody)	190887-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-LAR/PTPRF [N165/38R] (Recombinant Antibody)	191820-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-WAVE1/SCAR [K91/36R] (Recombinant Antibody)	190895-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-NCKX4 [N414/25R] (Recombinant Antibody)	191806-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Nav1.8 Na+ channel [N134/12R] (Recombinant Antibody)	192035-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-FGF13/FHF2 [N91/27.1R] (Recombinant Antibody)	191807-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-GABA(A)R, Alpha2 [N399/19R] (Recombinant Antibody)	190894-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-NALCN [N185/7R] (Recombinant Antibody)	190893-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-KChIP1 K+ channel [K55/7R] (Recombinant Antibody)	192036-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Pan-Nav channel [K58/35R] (Recombinant Antibody)	191809-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-mGluR1/5 [N75/3R] (Recombinant Antibody)	191810-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Synaptotagmin-7 [N275/14R] (Recombinant Antibody)	191811-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Pan-Nav1 Na+ channel [N419/78R] (Recombinant Antibody)	191812-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Kir2.3 K+ channel [N25/35R] (Recombinant Antibody)	191813-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-Lgi1 [N283/7R] (Recombinant Antibody)	191815-rAb	Zhuhao Wu	3/10/2023	Cornell University, Weill Medical College	US
Anti-6xHis [N144/14R] (Recombinant Antibody)	184180-rAb	Martin-Paul Agbaga	3/9/2023	University of Oklahoma Health Sciences Center	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	Katherine Roche	3/8/2023	National Institute of Neurological Disorders and Strokes (NINDS)	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	Katherine Roche	3/8/2023	National Institute of Neurological Disorders and Strokes (NINDS)	US
GFP scFv [N86/38]	182095	Dr Alan Fauconnier	3/8/2023	Culture in vivo ASBL	BE
Anti-GFP [N86/8R]	177572	Dr Alan Fauconnier	3/8/2023	Culture in vivo ASBL	BE
PSD-95 scFv [K28/43]	182066	Ji Sun	3/7/2023	St. Jude Children's Research Hospital	US
PSD-95 scFv [K28/38]	190487	Ji Sun	3/7/2023	St. Jude Children's Research Hospital	US
PSD-95 scFv [K28/42]	190488	Ji Sun	3/7/2023	St. Jude Children's Research Hospital	US
PSD-95 scFv [K28/43]	190489	Ji Sun	3/7/2023	St. Jude Children's Research Hospital	US
PSD-95 scFv [K28/74]	190490	Ji Sun	3/7/2023	St. Jude Children's Research Hospital	US
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Kurt De Vos	3/7/2023	University of Sheffield	GB
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Christiane Zweier	3/7/2023	Universitaet Bern	CH
Anti-CASPR/Neurexin IV [K65/35R] (Recombinant Antibody)	182999-rAb	Gerard Moloney	3/7/2023	University College Cork	IE
Anti-Thorase/Atad1 [N125/10R] (Recombinant Antibody)	184207-rAb	Matthew Wohlever	3/7/2023	University of Toledo	US
Anti-RGS14 [N133/21.2R] (Recombinant Antibody)	180088-rAb	Fuxman Bass	3/6/2023	Boston University Main Campus	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Yeun Ja Choi	3/6/2023	Dongguk University, Gyeongju	KR
Anti-Ankyrin-G [N106/36] (Recombinant Antibody trial size)	192039-rAb.T	Chi Wai Lee	3/5/2023	University of Hong Kong	HK
Anti-LRP4 (extracellular) [N207/27R] (Recombinant Antibody trial size)	184201-rAb.T	Chi Wai Lee	3/5/2023	University of Hong Kong	HK
Anti-GFAP [N206A/8R] (Recombinant Antibody)	193445-rAb	Anand Swaroop	3/2/2023	National Eye Institute (NEI)	US
Anti-Calbindin [L109/57R] (Recombinant Antibody)	193442-rAb	Anand Swaroop	3/2/2023	National Eye Institute (NEI)	US
Anti-GFP [N86/38.1R]	114492	Rudolf Leube	3/2/2023	Universitaetsklinikum Aachen	DE
Anti-ASIC1 [N271/44R] (Recombinant Antibody)	184198-rAb	Jeffrey Holt	3/1/2023	Boston Children's Hospital	US
Anti-HCN1 [N70/28R] (Recombinant Antibody)	180092-rAb	Jeffrey Holt	3/1/2023	Boston Children's Hospital	US
Anti-GluN1 [N308/48R]	177529	Katharina Schmack	3/1/2023	Francis Crick Institute	GB
Anti-GFP [N86/8R]	177572	Frank O. Fackelmayer	3/1/2023	Biomedical Research Institute (BRI-FORTH)	GR
Anti-GFP [N86/38.1R]	114492	Frank O. Fackelmayer	3/1/2023	Biomedical Research Institute (BRI-FORTH)	GR
Anti-Kv2.1 K+ channel [K89/34R] (Recombinant Antibody)	180083-rAb	Antonio Ferrer Montiel	3/1/2023	Universidad Miguel Hernandez	ES
Anti-GABA(A)R, Alpha4 [N398A/34R] (Recombinant Antibody trial size)	184208-rAb.T	Jeffrey Jones	2/28/2023	Medical University of South Carolina	US
Anti-Kv4.2 K+ channel [L28/4R] (Recombinant Antibody trial size)	180107-rAb.T	Takuma Mori	2/27/2023	Shinshu University	JP
Anti-CASK [K56A/50R] (Recombinant Antibody trial size)	183002-rAb.T	Takuma Mori	2/27/2023	Shinshu University	JP
Anti-Pan-QKI [N147/6.1R] (Recombinant Antibody trial size)	180114-rAb.T	Takuma Mori	2/27/2023	Shinshu University	JP
Anti-Ankyrin-G [N106/36] (Recombinant Antibody)	192039-rAb	Elizabeth Akin	2/27/2023	University of Nevada, Reno	US
Anti-TRIP8b (constant) [N212/17R] (Recombinant Antibody)	180109-rAb	Sake Ikeda	2/23/2023	University of Wisconsin, Madison	US
Anti-HCN2 [N71/37R] (Recombinant Antibody)	184178-rAb	Dominik Oliver	2/21/2023	Philipps-Universitaet Marburg	DE
Anti-Miro2 [N384/63R]	182114	Harvey McMahon	2/21/2023	MRC Laboratory of Molecular Biology	GB
HS63 pComb3xss anti-Homer1 nanobody	134715	Leszek Lisowski	2/19/2023	Children's Medical Research Institute	AU
Anti-Pan-Nav channel [K58/35R] (Recombinant Antibody)	191809-rAb	Hirohide Takebayashi	2/17/2023	Niigata University	JP
Anti-Pan-Nav channel [K58/35R] (Recombinant Antibody)	191809-rAb	Hirohide Takebayashi	2/17/2023	Niigata University	JP
Anti-Pan-Shank [N23B/49R]	128637	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-HCN1 [N70/28R]	114512	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GABA(A)R, Delta [N151/3.3R]	114515	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluK5/Grik5/KA2 kainate receptor [N279B/27R]	149451	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R]	177570	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluA2 [L21/32R]	177480	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluN2B [N59/20R]	177565	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-6xHis [N144/14R]	177500	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Neurexin-1-Beta [N170A/1.1R]	114530	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GST [N100/13R ]	188214	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Homer1 [L113/28R]	188189	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-TrpV3 [N15/39R]	188210	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluN2C [N422/18R]	177551	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-PICK1 [L20/8R]	128630	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GABA(A)R, Epsilon [N413/67R]	114478	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GABA(B)R2 [N81/37.1R]	114544	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Kv4.3 K+ channel [K75/41R]	128627	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Kv4.2 K+ Channel (External) [K57/1R]	128622	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-PSD-95 [K28/43R]	128618	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluN1 [N308/48R]	177529	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluN2A [N327/95R]	177531	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GFP [N86/38.1R]	114492	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Neuroligin-1 [N97A/31R]	114554	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-TrpV1 [N221/12R]	188224	Dr.Janesh Kumar	2/17/2023	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
C-Fos scFv [N486/32]	182090	Brian Wilhelm	2/16/2023	University of Montreal	CA
Anti-Co-Rest/RCOR1 [K72/8R]	140066	Matt Scaglione	2/16/2023	Duke University	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody trial size)	180087-rAb.T	Carlos Portera-Cailliau	2/14/2023	University of California, Los Angeles (UCLA)	US
Anti-VIP [L108/92R]	177453	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-Npas4 [N408/79]	177547	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-Olig1 [N149/25.1R]	114540	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-GFAP [N206A/8R]	177512	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-Parvalbumin [L114/81R]	177460	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-c-Fos [N486/76R]	177560	Hisashi Mori	2/14/2023	University of Toyama	JP
Anti-GFAP [N206A/8R] (Recombinant Antibody)	193445-rAb	Tracey Neel	2/13/2023	Jackson Laboratory	US
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Christophe Leterrier	2/13/2023	CNRS UMR 7051, Institut de neurophysiopathologie (INP)	FR
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Christophe Leterrier	2/13/2023	CNRS UMR 7051, Institut de neurophysiopathologie (INP)	FR
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody)	180093-rAb	Anthony J. Baucum II	2/10/2023	Indiana University-Purdue University Indianapolis (IUPUI)	US
Anti-GluA2 [L21/32R] (Recombinant Antibody)	184172-rAb	Anthony J. Baucum II	2/10/2023	Indiana University-Purdue University Indianapolis (IUPUI)	US
Anti-MMP9 matrix metalloproteinase-9 precursor [L51/82R]	149455	Wendy Gordon	2/10/2023	University of Minnesota	US
Anti-PSD-95 [K28/43R]	128618	ZhaoPu	2/9/2023	Northeast University, China	CN
Anti-GFP [N86/38.1R]	114492	Jose Rodriguez	2/8/2023	University of California, Los Angeles (UCLA)	US
Nav1.8 Na+ channel scFv [N134/12]	190530	Pierre Vanderhaeghen	2/8/2023	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-Cavbeta4 Ca2+ channel [N10/7R] (Recombinant Antibody)	182227-rAb	Robert A. Sweet	2/7/2023	University of Pittsburgh (University, School of Medicine, and Cancer Institute)	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Paul Geeleher	2/3/2023	St. Jude Children's Research Hospital	US
Anti-HCN1 [N70/28R] (Recombinant Antibody)	180092-rAb	John Bekkers	2/2/2023	Australian National University	AU
Anti-Nav1.1 Na+ channel [K74/71R] (Recombinant Antibody)	180089-rAb	Massimo Mantegazza	2/2/2023	CNRS UMR 7275, Institut de Pharmacologie Moleculaire et Cellulaire (IPMC)	FR
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Hanne Borger Rasmussen	2/2/2023	University of Copenhagen	DK
Anti-CASPR2 [K67/25R] (Recombinant Antibody trial size)	184177-rAb.T	Robert Gereau	1/31/2023	Washington University in Saint Louis	US
Anti-Nav1.7 Na+ channel [N68/6R]	177566	Keiichi Konoki	1/31/2023	Tohoku University	JP
Anti-Calbindin [L109/57R]	177455	Dies Meijer	1/25/2023	University of Edinburgh	GB
Anti-Parvalbumin [L114/3R]	177459	Dies Meijer	1/25/2023	University of Edinburgh	GB
Anti-Parvalbumin [L114/81R]	177460	Dies Meijer	1/25/2023	University of Edinburgh	GB
Nav1.8 Na+ channel scFv [N134/12]	190530	Martin Fussenegger	1/25/2023	ETH Zurich (Swiss Federal Institute of Technology)	CH
Nav1.8 Na+ channel scFv [N134/12]	190531	Martin Fussenegger	1/25/2023	ETH Zurich (Swiss Federal Institute of Technology)	CH
Anti-6xHis [N144/14R] (Recombinant Antibody)	184180-rAb	Rafael Delgado	1/24/2023	La Fundacion para la Investigacion Biomedica del Hospital Universitario 12 de Octubre	ES
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Kuo-Fen Lee	1/23/2023	Salk Institute for Biological Studies	US
Anti-GFP [N86/38.1R]	114492	Shahab Asgharzadeh	1/23/2023	Children's Hospital Los Angeles	US
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R] (Recombinant Antibody)	182998-rAb	Zhao-Wen Wang	1/23/2023	University of Connecticut Health Center	US
Anti-GABA(A)R, Alpha4 [N398A/34R]	177543	Kelvin C. Luk	1/23/2023	University of Pennsylvania	US
Anti-GFP [N86/8R] (Recombinant Antibody trial size)	184171-rAb.T	Roshan Shrestha	1/16/2023	Carlsbad Aquafarm	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Roshan Shrestha	1/16/2023	Carlsbad Aquafarm	US
Anti-PSD-95 [K28/74R] (Recombinant Antibody)	184184-rAb	Richard Huganir	1/13/2023	Johns Hopkins University and School of Medicine	US
GS8 pComb3xss anti-Gephyrin nanobody	145827	Hruska Martin	1/13/2023	West Virginia University and School of Medicine	US
GC92 pComb3xss anti-Gephyrin nanobody	145826	Hruska Martin	1/13/2023	West Virginia University and School of Medicine	US
GC1 pComb3xss anti-Gephyrin nanobody	134720	Hruska Martin	1/13/2023	West Virginia University and School of Medicine	US
Anti-ANO6/TMEM16F [N429/19]	190327	NIH/NICHD	1/13/2023	National Institute of Child Health and Human Development (NICHD)	US
Rufy3 scFv [N483/26]	190558	Victor Tarabykin	1/11/2023	Charite Universitaetsmedizin Berlin	DE
Anti-LRP4 (extracellular) [N207/27R] (Recombinant Antibody)	184201-rAb	Ruth Herbst	1/11/2023	Medical University of Vienna	AT
Anti-LRP4 (extracellular) [N207/27R]	177513	Ruth Herbst	1/11/2023	Medical University of Vienna	AT
LRP4 (extracellular) scFv [N207/27]	190537	Ruth Herbst	1/11/2023	Medical University of Vienna	AT
c-Fos scFv [N486/76]	190560	David Curiel	1/10/2023	Washington University in Saint Louis	US
Anti-6xHis [N144/14R]	177500	Lawrence Shapiro	1/9/2023	Columbia University	US
Anti-GluN1 [N308/48R]	177529	Connie Cepko	1/6/2023	Harvard Medical School	US
Anti-GluN2B [N59/20R]	177565	Connie Cepko	1/6/2023	Harvard Medical School	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Connie Cepko	1/6/2023	Harvard Medical School	US
Anti-GluN2A [N327/95R]	177531	Connie Cepko	1/6/2023	Harvard Medical School	US
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Andrew Carter	1/6/2023	MRC Laboratory of Molecular Biology	GB
Anti-Arl13b [N295B/66R] (Recombinant Antibody trial size)	180085-rAb.T	Adriano Aguzzi	1/5/2023	Zurich University Hospital	CH
Anti-Cavbeta4 Ca2+ channel [N10/7R]	177492	Prof. Dr. Markus Missler	1/5/2023	Universitaetsklinikum Muenster	DE
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Samia Joca	1/4/2023	Aarhus University	DK
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Erez Eitan	1/3/2023	NeuroDex	US
Anti-Npas4 [N408/79]	177547	Brenda Bloodgood	12/23/2022	University of California, San Diego (UCSD)	US
Anti-GFP [N86/38.1R]	114492	Son, YeonSung	12/19/2022	Seoul National University	KR
PSD-95 scFv [K28/43]	182066	Ji Sun	12/15/2022	St. Jude Children's Research Hospital	US
Anti-PSD-95 [K28/43R]	128618	Ji Sun	12/15/2022	St. Jude Children's Research Hospital	US
Anti-LRP4 (extracellular) [N207/27R] (Recombinant Antibody trial size)	184201-rAb.T	Cagla Eroglu	12/15/2022	Duke University	US
Anti-Pan-Gamma-Protocadherin-(constant) [N159/5R] (Recombinant Antibody)	184189-rAb	Morgan Sheng	12/14/2022	Broad Institute	US
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R] (Recombinant Antibody)	184192-rAb	Daisy Morales	12/12/2022	Pontifical Catholic University of Puerto Rico	PR
Anti-VGlut2 [N29/29R] (Recombinant Antibody)	180099-rAb	Shagun Bhardwaj	12/8/2022	National Institute of Immunology	IN
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Fredrik Sterky	12/8/2022	Goteborgs Universitet	SE
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Katarzyna Grochowska	12/6/2022	Universitaetsklinikum Hamburg-Eppendorf	DE
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Katarzyna Grochowska	12/6/2022	Universitaetsklinikum Hamburg-Eppendorf	DE
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Katarzyna Grochowska	12/6/2022	Universitaetsklinikum Hamburg-Eppendorf	DE
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Katarzyna Grochowska	12/6/2022	Universitaetsklinikum Hamburg-Eppendorf	DE
VGlut1 scFv [N28/9]	190545	Hiroyuki Hioki	12/6/2022	Juntendo University	JP
PSD-95 scFv [K28/74]	190490	Hiroyuki Hioki	12/6/2022	Juntendo University	JP
Bassoon scFv [L124/59]	190508	Hiroyuki Hioki	12/6/2022	Juntendo University	JP
VGlut2 scFv [N29/29]	182085	Hiroyuki Hioki	12/6/2022	Juntendo University	JP
Homer1L/S scFv [L113/130]	190501	Hiroyuki Hioki	12/6/2022	Juntendo University	JP
Anti-6xHis [N144/14R] (Recombinant Antibody trial size)	184180-rAb.T	Prof.T.Gasser	12/5/2022	Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)	DE
Anti-HCN1 [N70/28R] (Recombinant Antibody)	180092-rAb	SIMONA LODATO	12/5/2022	Humanitas University	IT
AC27 pEGFPN1 anti-AMIGO-1 nanobody	135226	Francois St-Pierre	12/1/2022	Baylor College of Medicine	US
AC50 pEGFPN1 anti-AMIGO-1 nanobody	135225	Francois St-Pierre	12/1/2022	Baylor College of Medicine	US
Anti-GABA(A)R, Alpha1 [N95/35R] (Recombinant Antibody)	184175-rAb	Kelvin Luk	12/1/2022	University of Pennsylvania	US
Anti-Gephyrin [L106/83R]	182100	Prof. G. Schwarz	11/29/2022	Universitaet zu Koeln	DE
TrpV1 scFv [N221/17]	190540	Oh Seok Kwon	11/29/2022	Korea Research Institute of Bioscience and Biotechnology	KR
Kir6.1 K+ channel scFv [N366/60]	190547	Jerod Denton	11/28/2022	Vanderbilt University	US
Anti-6xHis [N144/14R]	177500	Zoltan Konthur	11/22/2022	Bundesanstalt fuer Materialforschung und -pruefung (BAM)	DE
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Kurt De Vos	11/22/2022	University of Sheffield	GB
Anti-BBS3/Arl6 [N302/10R]	188211	Kazuhisa Nakayama	11/21/2022	Kyoto University, Graduate School of Pharmaceutical Sciences	JP
Anti-GFP [N86/8R]	177572	Kazuhisa Nakayama	11/21/2022	Kyoto University, Graduate School of Pharmaceutical Sciences	JP
Anti-WAVE1/SCAR [K91/36R]	128629	Prof. Dr. Christof Hauck	11/18/2022	Universitaet Konstanz	DE
Anti-6xHis [N144/14R]	177500	Prof. Dr. Christof Hauck	11/18/2022	Universitaet Konstanz	DE
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Zhao Zhang	11/16/2022	University of Texas Southwestern Medical Center	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody)	180087-rAb	Patrik Verstreken	11/15/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-Pan-Synapsin [L125/129R]	177472	Dr.Delgado	11/14/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-Ankyrin-B [N105/13R]	177493	Mingjie Zhang	11/14/2022	Hong Kong University of Science and Technology	HK
Anti-Ankyrin-B [N105/17R]	177494	Mingjie Zhang	11/14/2022	Hong Kong University of Science and Technology	HK
Anti-CASK [K56A/50R] (Recombinant Antibody trial size)	183002-rAb.T	Edouard Bertrand	11/10/2022	CNRS UMR 9002, Institut de Genetique Humaine (IGH)	FR
Anti-6xHis [N144/14R]	177500	lichun he	11/7/2022	Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences	CN
Anti-GABA(A)R, Theta [L123/46R]	188158	WEI LU	11/3/2022	National Institute of Neurological Disorders and Strokes (NINDS)	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Yi Zhou	11/2/2022	Florida State University, Tallahassee	US
Anti-Kv1.3 K+ channel [L23/27R] (Recombinant Antibody trial size)	183000-rAb.T	Mario Capecchi	11/1/2022	University of Utah	US
Anti-Copper ATPase 1 (Menke's disease protein) [L60/4R]	114502	Ji Miao	10/31/2022	Boston Children's Hospital	US
Anti-GFP [N86/38.1R]	114492	Haissi Cui	10/28/2022	University of Toronto	CA
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Carles Rentero	10/28/2022	Universitat de Barcelona	ES
HS22 pEYFPN1 anti-Homer1 nanobody	135219	Liam Holt	10/27/2022	New York University School of Medicine	US
Anti-Shank2 [N23B/6R]	177519	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-Shank1 [N22/21R]	177516	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-VGlut1 [N28/9R]	128638	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-VGAT [L118/80R]	177463	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-PSD-95 [K28/43R]	128618	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-VGlut2 [N29/29R]	114501	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-Shank3 [N69/46R]	140078	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-Gephyrin [L106/83R]	182100	Takeshi Uemura	10/27/2022	Shinshu University	JP
Anti-Bassoon [L124/59R]	177470	Takeshi Uemura	10/27/2022	Shinshu University	JP
GABA(A)R, gamma2 scFv [N452/81]	182088	Hirohide Iwasaki	10/27/2022	Gunma University	JP
Anti-RGS14 [N133/21.2R] (Recombinant Antibody)	180088-rAb	Mike McKenna	10/24/2022	NanoString Technologies	US
Anti-Shank3 [N69/46R] (Recombinant Antibody trial size)	180121-rAb.T	William SHIN	10/24/2022	National Institutes of Health Clinical Center (NIHCC)	US
Anti-Ataxin-1, 11NQ [N76/8R] (Recombinant Antibody)	180116-rAb	Michael Way	10/24/2022	Francis Crick Institute	GB
Anti-Shank3 [N69/46R] (Recombinant Antibody)	180121-rAb	Michael Way	10/24/2022	Francis Crick Institute	GB
Anti-GluN2B [N59/20R]	177565	Mark Bathe	10/20/2022	Massachusetts Institute of Technology	US
Anti-PSD-95 [K28/43R]	128618	Mark Bathe	10/20/2022	Massachusetts Institute of Technology	US
Anti-GluN2A [N327A/38R]	177532	Mark Bathe	10/20/2022	Massachusetts Institute of Technology	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	David Clapham	10/20/2022	HHMI, Janelia Research Campus	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	David Clapham	10/18/2022	HHMI, Janelia Research Campus	US
Anti-Kv1.2 K+ channel [L76/36R] (Recombinant Antibody trial size)	184220-rAb.T	Chuan Wu	10/13/2022	National Cancer Institute (NCI)	US
Anti-6xHis [N144/14R]	177500	Dan Mulvihill	10/13/2022	University of Kent	GB
Anti-Mortalin/GRP75 [N52A/42.1R] (Recombinant Antibody)	180091-rAb	Rosario Rizzuto	10/12/2022	University of Padua	IT
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Chunghun Lim	10/12/2022	Ulsan National Institute of Science and Technology (UNIST)	KR
Anti-GFP [N86/38.1R]	114492	Chunghun Lim	10/12/2022	Ulsan National Institute of Science and Technology (UNIST)	KR
GC83 pComb3xss anti-Gephyrin nanobody	134721	Lin Tian	10/11/2022	University of California, Davis	US
Anti-LRRK2/Dardarin, C-terminus [N241A/34R]	177520	Dario Alessi	10/11/2022	University of Dundee	GB
Anti-CASPR/Neurexin IV [K65/35R] (Recombinant Antibody trial size)	182999-rAb.T	Fredrik Sterky	10/6/2022	Goteborgs Universitet	SE
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Takeshi Uemura	10/5/2022	Shinshu University	JP
Anti-VAChT [N6/38R]	182117	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-LRP4 (cytoplasmic) [N164/6.1R]	114542	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-GluN2B [N59/20R]	177565	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-GluK5/Grik5/KA2 kainate receptor [N279B/27R]	149451	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-SVOP [N356/23R]	114499	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R]	177570	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-CASK [K56A/50R]	177443	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-Cav1.2/1.3 Ca2+ channel [L57/46R]	177485	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-Nav1.7 Na+ channel [N68/6R]	177566	NAOKI WATANABE	10/2/2022	Kyoto University, Graduate School of Medicine	JP
Anti-GFP [N86/38.1R]	114492	Piotr Rieske	9/30/2022	Medical University of Lodz	PL
Anti-6xHis [N144/14R]	177500	Piotr Rieske	9/30/2022	Medical University of Lodz	PL
GFP scFv [N86/38]	182095	Kazuhisa Nakayama	9/30/2022	Kyoto University, Graduate School of Pharmaceutical Sciences	JP
Anti-GFP [N86/38.1R]	114492	Kazuhisa Nakayama	9/30/2022	Kyoto University, Graduate School of Pharmaceutical Sciences	JP
Anti-SCG10/Stathmin-2 [L5/1R]	140065	Prof. Dr. Ivan Bogeski	9/29/2022	Universitaetsmedizin Goettingen	DE
Anti-VDAC1 [N152B/23R] (Recombinant Antibody)	184197-rAb	Denise Inman	9/28/2022	University of North Texas Health Science Center	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Jiri Lukas	9/28/2022	University of Copenhagen	DK
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Jiri Lukas	9/28/2022	University of Copenhagen	DK
Calbindin scFv [L109/57]	182071	Heng Zhu	9/27/2022	Johns Hopkins University and School of Medicine	US
Anti-6xHis [N144/14R]	177500	Dr. Roshan Thakur	9/27/2022	Institute for Research in Biomedicine, Switzerland	CH
Anti-GABA(A)R, Delta [N151/3.3R] (Recombinant Antibody)	180118-rAb	F Gregory Wulczyn	9/26/2022	Charite Universitaetsmedizin Berlin	DE
Anti-VGlut2 [N29/29R] (Recombinant Antibody)	180099-rAb	F Gregory Wulczyn	9/26/2022	Charite Universitaetsmedizin Berlin	DE
Anti-VGlut1 [N28/9R] (Recombinant Antibody)	180087-rAb	F Gregory Wulczyn	9/26/2022	Charite Universitaetsmedizin Berlin	DE
Anti-GFP [N86/38.1R]	114492	Ming-Han Tsai	9/21/2022	National Yang Ming Chiao Tung University	TW
Anti-Shank3 [N69/46R] (Recombinant Antibody trial size)	180121-rAb.T	Will Lockwood	9/20/2022	British Columbia Cancer Agency	CA
Anti-Synaptotagmin-7 [N275/14R]	177526	daniel choquet	9/20/2022	CNRS, Delegation Aquitaine	FR
Anti-GluK5/Grik5/KA2 kainate receptor [N279B/27R]	149451	daniel choquet	9/20/2022	CNRS, Delegation Aquitaine	FR
Anti-GFP [N86/38.1R]	114492	daniel choquet	9/20/2022	CNRS, Delegation Aquitaine	FR
Anti-Pan-Neurofascin (extracellular) [A12/18R]	177438	Nathalie Sans	9/15/2022	Delegation INSERM Nouvelle-Aquitaine	FR
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Prof. Volker Haucke	9/14/2022	Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie	DE
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Prof. Volker Haucke	9/14/2022	Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie	DE
Anti-TRPML3/Mucolipin-3 [N268/19R]	114477	Stanley Thomas Carmichael	9/13/2022	University of California, Los Angeles (UCLA)	US
Anti-PSD-95 [K28/43R]	128618	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-GFP [N86/38.1R]	114492	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-GluN2A [N327A/38R]	177532	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Bassoon scFv [L124/59]	182078	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-TARPGamma2/Stargazin [N245/1R]	177521	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-SAPAP3 [L126/93R]	177473	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-TARPGamma2/4/8 [N245/36R]	177522	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-GluN2A [N327/95R]	177531	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-Shank3 [N69/46R]	140078	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Dr.Delgado	9/12/2022	Loyola University Chicago, College of Arts and Sciences	US
GFP scFv [N86/38]	182095	Qinwen Mao	9/11/2022	University of Utah	US
Anti-NrCAM [N343/26R]	177534	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-Pan-Neurofascin (extracellular) [A12/18R]	177438	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-Ankyrin-G (blotting) [N106/20R]	177495	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
CASPR/Neurexin IV scFv [K65/35]	182068	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-Ankyrin-B [N105/13R]	177493	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-SynCAM1 [L45/30R]	177482	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-Ankyrin-B [N105/17R]	177494	Elior Peles	9/11/2022	Weizmann Institute of Science	IL
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Christopher Cunningham	9/8/2022	University of Pittsburgh (University, School of Medicine, and Cancer Institute)	US
Anti-TrpM7 [N74/25R]	177569	Benjamin Chun-Kit TONG	9/8/2022	Hong Kong Baptist University	HK
Anti-GFP [N86/38.1R]	114492	James Park	9/6/2022	VA Medical Center - East Orange NJ	US
Anti-Arl13b [N295B/66R]	140076	Masashi Kishi	9/5/2022	Research Institute, Nozaki Tokushukai Hospital	JP
Anti-Arl13b [N295B/66R] (Recombinant Antibody trial size)	180085-rAb.T	Masashi Kishi	9/5/2022	Research Institute, Nozaki Tokushukai Hospital	JP
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Dynlacht	9/1/2022	New York University School of Medicine	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody trial size)	180087-rAb.T	Michael Salling	8/31/2022	Louisiana State University Health Sciences Center, New Orleans	US
Anti-HCN1 [N70/28R] (Recombinant Antibody)	180092-rAb	Michael Salling	8/31/2022	Louisiana State University Health Sciences Center, New Orleans	US
Anti-VGlut2 [N29/29R] (Recombinant Antibody trial size)	180099-rAb.T	Michael Salling	8/31/2022	Louisiana State University Health Sciences Center, New Orleans	US
Anti-TRIP8b (constant) [N212/17R] (Recombinant Antibody trial size)	180109-rAb.T	Michael Salling	8/31/2022	Louisiana State University Health Sciences Center, New Orleans	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody trial size)	180082-rAb.T	Michael Salling	8/31/2022	Louisiana State University Health Sciences Center, New Orleans	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Gerard Moloney	8/31/2022	University College Cork	IE
Anti-HCN2 [N71/37R]	177567	Lei Zhou	8/31/2022	Shenzhen Bay Laboratory	CN
Anti-HCN1 [N70/28R]	114512	Lei Zhou	8/31/2022	Shenzhen Bay Laboratory	CN
Anti-Shank3 [N69/46R]	140078	Lei Zhou	8/31/2022	Shenzhen Bay Laboratory	CN
Anti-HCN4 [N114/10.1R]	114506	Lei Zhou	8/31/2022	Shenzhen Bay Laboratory	CN
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	David MacLean	8/26/2022	University of Rochester Medical Center	US
Anti-GFP [N86/38.1R]	114492	David MacLean	8/26/2022	University of Rochester Medical Center	US
Anti-GluA2 [L21/32R]	177480	David MacLean	8/26/2022	University of Rochester Medical Center	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Laura Lackner	8/26/2022	Northwestern University	US
Anti-GABA(A)R, Alpha4 [N398A/34R] (Recombinant Antibody)	184208-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GABA(A)R, Alpha5 [N415/24R] (Recombinant Antibody)	184218-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-LRP4 (extracellular) [N207/27R] (Recombinant Antibody)	184201-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R] (Recombinant Antibody)	184192-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-BK beta4 K+ channel [L18A/3R] (Recombinant Antibody)	184221-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-ASIC1 [N271/44R] (Recombinant Antibody)	184198-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Shank2 [N23B/6R] (Recombinant Antibody)	184186-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-QKI-7 [N183/15R] (Recombinant Antibody)	184209-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-FGF14/FHF4 [N56/21R] (Recombinant Antibody)	184195-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-PSD-95 [K28/74R] (Recombinant Antibody)	184184-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cav3.2 Ca2+ channel [N55/10R] (Recombinant Antibody)	184196-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-PSD-93/Chapsyn-110 [N18/28R] (Recombinant Antibody)	184210-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv7.1/KCNQ1 K+ channel [N37A/10R] (Recombinant Antibody)	188458-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cav1.2 Ca2+ channel [N263/31R] (Recombinant Antibody)	184183-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-BAF53b [N332B/15R] (Recombinant Antibody)	184200-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Mitofusin-1 [N111/24R] (Recombinant Antibody)	184214-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-ANO5/TMEM16E [N421A/85R] (Recombinant Antibody)	184215-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Beta4-spectrin [N393/2R] (Recombinant Antibody)	184223-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GIT1 [N39B/8R] (Recombinant Antibody)	184202-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-VGlut3 [N34/34.2R] (Recombinant Antibody)	184216-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Ankyrin-B [N105/13R] (Recombinant Antibody)	184191-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-MAP3K12 [N377/20R] (Recombinant Antibody)	184176-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-TARPGamma2/Stargazin [N245/1R] (Recombinant Antibody)	184199-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GABA(B)R2 [N81/37.1R] (Recombinant Antibody)	184217-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.2 K+ channel [L76/36R] (Recombinant Antibody)	184220-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-ADAM22 (cytoplasmic) [N46/30R] (Recombinant Antibody)	184219-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Dopamine D2 receptor [N186/29R] (Recombinant Antibody)	184204-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cavbeta2 Ca2+ channel [N8B/1R] (Recombinant Antibody)	184206-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-VDAC1 [N152B/23R] (Recombinant Antibody)	184197-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Beta4-spectrin [N393/76R] (Recombinant Antibody)	184187-rAb	Zhuhao Wu	8/23/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Brian Lazzaro	8/19/2022	Cornell University	US
Anti-VGlut2 [N29/29R] (Recombinant Antibody trial size)	180099-rAb.T	Dr. Arnab Barik	8/17/2022	Indian Institute of Science, Bangalore	IN
Anti-LRP4 (extracellular) [N207/27R]	177513	O'Connor, Kevin Phd	8/16/2022	Yale University	US
Anti-GluA2 [L21/32R] (Recombinant Antibody trial size)	184172-rAb.T	David MacLean	8/12/2022	University of Rochester Medical Center	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody trial size)	180093-rAb.T	David MacLean	8/12/2022	University of Rochester Medical Center	US
Anti-GFP [N86/38.1R]	114492	Huang Yu	8/9/2022	City University of Hong Kong	HK
Anti-GFP [N86/38.1R]	114492	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-Olig1 [N149/25.1R]	114540	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Bassoon scFv [L124/59]	182078	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-Gephyrin [L106/83R]	182100	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-GFAP [N206A/8R]	177512	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-VDAC1 [N152B/23R]	177502	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-GAD65/67 [L127/12R]	177474	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Parvalbumin scFv [L114/3]	182072	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
PSD-95 scFv [K28/43]	182066	Huaxi Xu	8/8/2022	Chongqing Medical University	CN
Anti-GFP [N86/38.1R]	114492	Takeo Saneyoshi	8/7/2022	Kyoto University, Graduate School of Medicine	JP
Nav1.7 Na+ channel scFv [N68/6]	182094	Huang Xianfeng	8/1/2022	Changzhou University	CN
Anti-GFP [N86/38.1R]	114492	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-VGlut1 [N28/9R]	128638	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-PSD-95 [K28/74R]	177439	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-Gephyrin [L106/83R]	182100	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-c-Fos [N486/32R]	177559	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-VIP [L108/92R]	177453	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-VGAT [L118/80R]	177463	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-PSD-95 [K28/43R]	128618	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-Parvalbumin [L114/3R]	177459	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-c-Fos [N486/76R]	177560	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-Homer1L [L113/27R]	177458	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-VGlut2 [N29/29R]	114501	Hiroyuki Hioki	8/1/2022	Juntendo University	JP
Anti-VGlut3 [N34/34.2R]	114494	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-c-Fos [N486/32R]	177559	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(B)R2 [N81/37.1R]	114544	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Ankyrin-R [N388A/10R]	114479	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Pan-Neurofascin (extracellular) [A12/18R]	177438	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Parvalbumin [L114/3R]	177459	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Neuroligin-2 [L107/39R]	177452	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Parvalbumin [L114/81R]	177460	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Npas4 [N408/79]	177547	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-VGAT [L118/80R]	177463	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-VIP [L108/92R]	177453	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-GIT1 [N39B/8R]	177545	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-nNOS/NOS1 [L121/25R]	177466	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Ankyrin-G (blotting) [N106/20R]	177495	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Ankyrin-G (staining) [N106/43R]	128635	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-PICK1 [L20/8R]	128630	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-Gephyrin [L106/83R]	182100	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-MECP2 [N227/21R]	177518	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
Anti-c-Fos [N486/76R]	177560	Mingjie Zhang	7/28/2022	Hong Kong University of Science and Technology	HK
HS38 pEYFPN1 anti-Homer1 nanobody	135221	Carol V Robinson	7/27/2022	University of Oxford	GB
GC1 pComb3xss anti-Gephyrin nanobody	134720	Carol V Robinson	7/27/2022	University of Oxford	GB
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Carol V Robinson	7/27/2022	University of Oxford	GB
Anti-Neuroligin-4* [N98/7R]	140081	Akio Fukumori	7/26/2022	Osaka Medical and Pharmaceutical University	JP
Anti-NGL-3/LRRC4B [N51/6.2R]	114493	Akio Fukumori	7/26/2022	Osaka Medical and Pharmaceutical University	JP
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Akio Fukumori	7/26/2022	Osaka Medical and Pharmaceutical University	JP
Anti-Ankyrin-G (blotting) [N106/20R]	177495	Oscar Cerda	7/22/2022	Universidad de Chile	CL
Mortalin/GRP75 scFv [N52A/42]	182091	Oscar Cerda	7/22/2022	Universidad de Chile	CL
Anti-Histone H3.3 [N158/28R]	182106	Oscar Cerda	7/22/2022	Universidad de Chile	CL
Anti-Slo1/BKAlpha maxi-K+ channel (Mouse) [L6/23R]	128634	Oscar Cerda	7/22/2022	Universidad de Chile	CL
Anti-Kv1.1 K+ channel [K20/78R] (Recombinant Antibody)	180098-rAb	Joesch	7/21/2022	Institute of Science and Technology Austria (I.S.T. Austria)	AT
C-Fos scFv [N486/32]	182090	Bryan Brensinger	7/20/2022	Johns Hopkins University Applied Physics Laboratory	US
Calbindin scFv [L109/57]	182071	Bryan Brensinger	7/20/2022	Johns Hopkins University Applied Physics Laboratory	US
GFP scFv [N86/38]	182095	Bryan Brensinger	7/20/2022	Johns Hopkins University Applied Physics Laboratory	US
Cav1.2 Ca2+ channel scFv [N263/31]	182083	Bryan Brensinger	7/20/2022	Johns Hopkins University Applied Physics Laboratory	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Wen-Hsuan Chang	7/19/2022	AcuraStem Inc.	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody trial size)	180093-rAb.T	JoÃ£o Relvas	7/17/2022	Universidade do Porto, Instituto de InvestigaÃ§Ã£o e InovaÃ§Ã£o em SaÃºde da (i3S)	PT
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody)	180093-rAb	Lynette Lim	7/15/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-GluA2 [L21/32R] (Recombinant Antibody trial size)	184172-rAb.T	Lynette Lim	7/15/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-GABA(A)R, Delta [N151/3.3R] (Recombinant Antibody)	180118-rAb	Lynette Lim	7/15/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Aldh1L1 scFv [N103/31]	182080	Guillermina Lopez Bendito	7/12/2022	Instituto de Neurociencias de Alicante	ES
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	Nitima Suttipanta	7/11/2022	Ubon Ratchathani University	TH
Anti-GFP [N86/38.1R]	114492	Peter Glazer	7/5/2022	Yale University	US
Anti-VGlut1 [N28/9R]	128638	Mark Bathe	7/5/2022	Massachusetts Institute of Technology	US
Anti-SAP97 [K64/15R]	128624	jÃ©rÃ´me Devaux	7/4/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-GFP [N86/38.1R]	114492	Christine Luttermann	6/30/2022	Friedrich-Loeffler-Institut (FLI)	DE
Anti-GABA(A)R, Alpha1 [N95/35R]	177574	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-PSD-95 [K28/43R]	128618	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-VAChT [N6/38R]	182117	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-GABA(A)R, Gamma2L [N452/81R]	177554	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-Pan-Synapsin [L125/129R]	177472	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-GABA(A)R, Alpha2 [N399/19R]	177544	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-6xHis [N144/14R]	177500	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-Gephyrin [L106/83R]	182100	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-VGlut2 [N29/29R]	114501	Gonzalo E. YÃ©venes	6/24/2022	Universidad de Concepcion	CL
Anti-GFP [N86/38.1R]	114492	TORU OKAMOTO	6/24/2022	Osaka University	JP
Anti-6xHis [N144/14R]	177500	TORU OKAMOTO	6/24/2022	Osaka University	JP
Anti-Mortalin/GRP75 [N52A/42.1R] (Recombinant Antibody)	180091-rAb	Ravi K. Singh	6/21/2022	Medical College of Wisconsin	US
C-Fos scFv [N486/32]	182090	Markus Landthaler	6/21/2022	Max-Delbrueck-Centrum fuer Molekulare Medizin (MDC)	DE
Nav1.7 Na+ channel scFv [N68/6]	182094	Lubin Chen	6/20/2022	Sixth People's Hospital, Shanghai Jiao Tong University 	CN
Anti-6xHis [N144/14R]	177500	Gang Pei	6/16/2022	Friedrich-Loeffler-Institut (FLI)	DE
Anti-PSD-95 [K28/43R] (Recombinant Antibody trial size)	180082-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GluA2 [L21/32R] (Recombinant Antibody trial size)	184172-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-LRRK2/Dardarin, C-terminus [N241A/34R] (Recombinant Antibody trial size)	184170-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv1.4 K+ channel [K13/31R] (Recombinant Antibody trial size)	180122-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Nav1.1 Na+ channel [K74/71R] (Recombinant Antibody trial size)	180089-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Copper ATPase 1 [L60/4R] (Recombinant Antibody trial size)	180115-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv1.2 K+ channel [K14/16R] (Recombinant Antibody trial size)	180086-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-SynCAM4 [N244/5R] (Recombinant Antibody trial size)	180105-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-HCN3 [N141/28R] (Recombinant Antibody trial size)	184203-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-CASPR2 [K67/25R] (Recombinant Antibody trial size)	184177-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Ataxin-1, 11NQ [N76/8R] (Recombinant Antibody trial size)	180116-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-VGlut2 [N29/29R] (Recombinant Antibody trial size)	180099-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-KCNT1/Slo2.2/Slack K+ channel [N3/26R] (Recombinant Antibody trial size)	180117-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-RGS14 [N133/21.2R] (Recombinant Antibody trial size)	180088-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Shank3 [N69/46R] (Recombinant Antibody trial size)	180121-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GABA(A)R, Delta [N151/3.3R] (Recombinant Antibody trial size)	180118-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv2.1 K+ channel (External) [K39/25R] (Recombinant Antibody trial size)	180104-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R] (Recombinant Antibody trial size)	180102-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Neuroligin-3 [N110/29.4R] (Recombinant Antibody trial size)	180120-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GABA(A)R, Alpha1 [N95/35R] (Recombinant Antibody trial size)	184175-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Nav1.7 Na+ channel [N68/6R] (Recombinant Antibody trial size)	184173-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody trial size)	180087-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Neurexin-1-Beta [N170A/1.1R] (Recombinant Antibody trial size)	180100-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Pan-QKI [N147/6.1R] (Recombinant Antibody trial size)	180114-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody trial size)	180085-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-VDAC1 [N152B/23R] (Recombinant Antibody trial size)	184197-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-KCNT2/Slo2.1/Slick K+ channel [N11/33R] (Recombinant Antibody trial size)	180119-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody trial size)	184174-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Pan-Shank [N23B/49R] (Recombinant Antibody trial size)	180095-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-SUR2A [N319A/14R] (Recombinant Antibody trial size)	183004-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv1.1 K+ channel [K20/78R] (Recombinant Antibody trial size)	180098-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Ankyrin-B [N105/13R] (Recombinant Antibody trial size)	184191-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R] (Recombinant Antibody trial size)	182998-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody trial size)	180093-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv4.2 K+ channel [L28/4R] (Recombinant Antibody trial size)	180107-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Cavbeta1 Ca2+ channel [N7/18.1R] (Recombinant Antibody trial size)	180108-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv4.3 K+ channel [K75/41R] (Recombinant Antibody trial size)	180097-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-TrpC1 [1F1R] (Recombinant Antibody trial size)	182228-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GluN1 [N308/48R] (Recombinant Antibody trial size)	182200-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Cavbeta4 Ca2+ channel [N10/7R] (Recombinant Antibody trial size)	182227-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv7.4/KCNQ4 K+ channel [N43/6R] (Recombinant Antibody trial size)	184193-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-KChIP2b K+ channel [K60/73R] (Recombinant Antibody trial size)	182226-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Cav1.2/1.3 Ca2+ channel [L57/46R] (Recombinant Antibody trial size)	182223-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kir2.1 K+ channel [N112B/14R] (Recombinant Antibody trial size)	182222-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-HCN4 [N114/10.1R] (Recombinant Antibody trial size)	180096-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv3.4 K+ channel [N72/16R] (Recombinant Antibody trial size)	184194-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody trial size)	180094-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv1.5 K+ channel [K7/45R] (Recombinant Antibody trial size)	180090-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Olig1 [N149/25.1R] (Recombinant Antibody trial size)	180103-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-TRIP8b (constant) [N212/17R] (Recombinant Antibody trial size)	180109-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-CASPR/Neurexin IV [K65/35R] (Recombinant Antibody trial size)	182999-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Cav3.1 Ca2+ channel [N178A/9.1R] (Recombinant Antibody trial size)	180106-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Ankyrin-B [N105/17R] (Recombinant Antibody trial size)	184188-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-SUR1 [N289/16R] (Recombinant Antibody trial size)	180113-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Iduna/RNF146 [N201/35R] (Recombinant Antibody trial size)	180112-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Mortalin/GRP75 [N52A/42.1R] (Recombinant Antibody trial size)	180091-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Navbeta4 Na+ channel [N168/6.3R] (Recombinant Antibody trial size)	180111-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Contactin/F3 [K73/20R] (Recombinant Antibody trial size)	183003-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Pan-Gamma-Protocadherin-(constant) [N159/5R] (Recombinant Antibody trial size)	184189-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-HCN1 [N70/28R] (Recombinant Antibody trial size)	180092-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-CASK [K56A/50R] (Recombinant Antibody trial size)	183002-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv1.3 K+ channel [L23/27R] (Recombinant Antibody trial size)	183000-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-MMP9 precursor [L51/82R] (Recombinant Antibody trial size)	180110-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv2.1 K+ channel [K89/34R] (Recombinant Antibody trial size)	180083-rAb.T	Kwanghun Chung	6/15/2022	Massachusetts Institute of Technology	US
Anti-Kv7.4/KCNQ4 K+ channel [N43/6R] (Recombinant Antibody)	184193-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Pan-Gamma-Protocadherin-(constant) [N159/5R] (Recombinant Antibody)	184189-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-HCN3 [N141/28R] (Recombinant Antibody)	184203-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv3.4 K+ channel [N72/16R] (Recombinant Antibody)	184194-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Ankyrin-B [N105/17R] (Recombinant Antibody)	184188-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GABA(A)R, Delta [N151/3.3R] (Recombinant Antibody)	180118-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-CASPR2 [K67/25R] (Recombinant Antibody)	184177-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cavbeta1 Ca2+ channel [N7/18.1R] (Recombinant Antibody)	180108-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-KChIP2b K+ channel [K60/73R] (Recombinant Antibody)	182226-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cav1.2/1.3 Ca2+ channel [L57/46R] (Recombinant Antibody)	182223-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Pan-Shank [N23B/49R] (Recombinant Antibody)	180095-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kir2.1 K+ channel [N112B/14R] (Recombinant Antibody)	182222-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Neurexin-1-Beta [N170A/1.1R] (Recombinant Antibody)	180100-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Olig1 [N149/25.1R] (Recombinant Antibody)	180103-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Pan-QKI [N147/6.1R] (Recombinant Antibody)	180114-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-TrpC1 [1F1R] (Recombinant Antibody)	182228-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Copper ATPase 1 [L60/4R] (Recombinant Antibody)	180115-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-KCNT1/Slo2.2/Slack K+ channel [N3/26R] (Recombinant Antibody)	180117-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-KCNT2/Slo2.1/Slick K+ channel [N11/33R] (Recombinant Antibody)	180119-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Neuroligin-3 [N110/29.4R] (Recombinant Antibody)	180120-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Shank3 [N69/46R] (Recombinant Antibody)	180121-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.4 K+ channel [K13/31R] (Recombinant Antibody)	180122-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cavbeta4 Ca2+ channel [N10/7R] (Recombinant Antibody)	182227-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GluN1 [N308/48R] (Recombinant Antibody)	182200-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R] (Recombinant Antibody)	182998-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-CASPR/Neurexin IV [K65/35R] (Recombinant Antibody)	182999-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.3 K+ channel [L23/27R] (Recombinant Antibody)	183000-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-CASK [K56A/50R] (Recombinant Antibody)	183002-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GABA(A)R, Alpha1 [N95/35R] (Recombinant Antibody)	184175-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Pan-Neurofascin (extracellular) [A12/18R] (Recombinant Antibody)	184174-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Nav1.7 Na+ channel [N68/6R] (Recombinant Antibody)	184173-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GluA2 [L21/32R] (Recombinant Antibody)	184172-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Contactin/F3 [K73/20R] (Recombinant Antibody)	183003-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.5 K+ channel [K7/45R] (Recombinant Antibody)	180090-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-LRRK2/Dardarin, C-terminus [N241A/34R] (Recombinant Antibody)	184170-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-SUR2A [N319A/14R] (Recombinant Antibody)	183004-rAb	Zhuhao Wu	6/14/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GluA2 [L21/32R]	177480	Ulrik Gether	6/14/2022	University of Copenhagen	DK
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Ulrik Gether	6/14/2022	University of Copenhagen	DK
Anti-PSD-95 [K28/43R]	128618	Ulrik Gether	6/14/2022	University of Copenhagen	DK
Anti-Homer1L/S [L113/130R]	177457	Lin Tian	6/13/2022	University of California, Davis	US
Anti-Bassoon [L124/59R]	177470	Lin Tian	6/13/2022	University of California, Davis	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Dynlacht	6/10/2022	New York University School of Medicine	US
Anti-GFP [N86/38.1R]	114492	Ryo Ushioda	6/9/2022	Kyoto Sangyo University	JP
Anti-HCN3 [N141/28R]	177499	Elias Leiva	6/8/2022	Universidad de Santiago de Chile	CL
Anti-HCN2 [N71/37R]	177567	Elias Leiva	6/8/2022	Universidad de Santiago de Chile	CL
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Claudia Lukas	6/8/2022	University of Copenhagen	DK
Anti-Shank3 [N69/46R]	140078	Prof. Dr. Markus Missler	6/7/2022	Universitaetsklinikum Muenster	DE
Anti-PSD-95 [K28/43R]	128618	Prof. Dr. Markus Missler	6/7/2022	Universitaetsklinikum Muenster	DE
Anti-Neuroligin-4* [N98/7R]	140081	Prof. Dr. Markus Missler	6/7/2022	Universitaetsklinikum Muenster	DE
Anti-GFP [N86/38.1R]	114492	Eva Goellner	6/6/2022	University of Kentucky	US
Anti-GFP [N86/38.1R]	114492	Dr. Chris Garcia	6/3/2022	Stanford University	US
Anti-Pan-Nav channel [K58/35R]	128623	O'Connor, Kevin Phd	6/2/2022	Yale University	US
C1-82 pComb3xss anti-cFos nanobody	145829	Amin Arnaout	6/1/2022	Massachusetts General Hospital	US
Anti-GFP [N86/38.1R]	114492	Giovanna Roncador	5/31/2022	Centro Nacional de Investigaciones Oncologicas (CNIO)	ES
Anti-Homer1L [L113/27R]	177458	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-Shank2 [N23B/6R]	177519	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-PICK1 [L20/8R]	128630	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-Shank1 [N22/21R]	177516	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-Kv4.2 K+ Channel (External) [K57/1R]	128622	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-GABA(A)R, Beta3 [N87/25R]	177573	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-Homer1L/S [L113/130R]	177457	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-PSD-93/Chapsyn-110 [N18/30R]	177506	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-Shank3 [N69/46R]	140078	Kazuhisa Kohda	5/31/2022	St. Marianna University School of Medicine	JP
Anti-GFP [N86/38.1R]	114492	Joshua Breunig	5/25/2022	Cedars-Sinai Medical Center	US
Anti-GFP [N86/38.1R]	114492	Rohit K Jangra	5/24/2022	Louisiana State University Health Sciences Center, Shreveport	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Rohit K Jangra	5/24/2022	Louisiana State University Health Sciences Center, Shreveport	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Oscar Cerda	5/24/2022	Universidad de Chile	CL
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Sang H Lee	5/23/2022	Medical College of Wisconsin	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Sang H Lee	5/23/2022	Medical College of Wisconsin	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Mark Moehle	5/22/2022	University of Florida	US
HS63 pComb3xss anti-Homer1 nanobody	134715	Bernard N. Kanoi	5/17/2022	Mount Kenya University	KE
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Cecile Charrier	5/13/2022	INSERM U1024, IBENS, Institut de Biologie de l'Ecole Normale SupÃ©rieure	FR
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Cecile Charrier	5/13/2022	INSERM U1024, IBENS, Institut de Biologie de l'Ecole Normale SupÃ©rieure	FR
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Terence Ndonyi Bukong	5/12/2022	INRS-Institut Armand Frappier	CA
Anti-c-Fos [N486/76R]	177560	Miki Imanishi	5/9/2022	Kyoto University, Institute for Chemical Research	JP
Anti-PINK1 [N4/15R]	177546	Chen Lab	5/3/2022	University of Minnesota	US
Anti-SynCAM4 [N244/5R]	114562	Chen Lab	5/3/2022	University of Minnesota	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Aurelien Roux	5/3/2022	University of Geneva	CH
GFP scFv [N86/38]	182095	Gary CH Mo	5/2/2022	University of Illinois at Chicago	US
Anti-6xHis [N144/14R]	177500	VALENZUELA LEON, PAOLA CAROLIN	4/29/2022	National Institute of Allergy and Infectious Diseases (NIAID)	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Sunghoe Chang	4/29/2022	Seoul National University	KR
Anti-c-Fos [N486/32R]	177559	Min Jae Lee	4/28/2022	Seoul National University	KR
GFP scFv [N86/38]	182095	Min Jae Lee	4/28/2022	Seoul National University	KR
C-Fos scFv [N486/32]	182090	Min Jae Lee	4/28/2022	Seoul National University	KR
S2-77 pComb3xss anti-cFos nanobody	145834	Min Jae Lee	4/28/2022	Seoul National University	KR
VGlut1 scFv [N28/9]	182084	Mark Bathe	4/28/2022	Massachusetts Institute of Technology	US
Anti-Pan-Neurofascin (extracellular) [A12/18R]	177438	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-NrCAM [N343/26R]	177534	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-TRIP8b (constant) [N212/17R]	114557	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-Ankyrin-B [N105/17R]	177494	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-HCN1 [N70/28R]	114512	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-Nav1.7 Na+ channel [N68/6R]	177566	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-GFP [N86/38.1R]	114492	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-Beta4-spectrin [N393/76R]	177542	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-6xHis [N144/14R]	177500	jÃ©rÃ´me Devaux	4/28/2022	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-GFP [N86/8R]	177572	Junichi Ikenouchi	4/27/2022	Kyushu University	JP
Anti-Kv2.1 K+ channel [K89/34R] (Recombinant Antibody trial size)	180083-rAb.T	Daniel McGehee	4/27/2022	University of Chicago	US
Anti-Kv2.1 K+ channel (External) [K39/25R] (Recombinant Antibody trial size)	180104-rAb.T	Daniel McGehee	4/27/2022	University of Chicago	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Arnold S. Kristof	4/27/2022	Research Institute of the McGill University Health Centre	CA
Anti-GABA(A)R, Alpha4 [N398A/34R]	177543	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, alpha6 [N229A/32R]	164155	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Epsilon [N413/67R]	114478	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Delta [N151/3.3R]	114515	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, alpha6 [N229A/32R]	164155	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Epsilon [N413/67R]	114478	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Alpha4 [N398A/34R]	177543	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Delta [N151/3.3R]	114515	Joanne Chan	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GFP [N86/38.1R]	114492	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-SAP102 [N19/2R]	177510	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
HS63 pComb3xss anti-Homer1 nanobody	134715	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GluN2A [N327/95R]	177531	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Neuroligin-1 [N97A/31R]	114554	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-TARPGamma2/4/8 [N245/36R]	177522	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-TARPGamma2/Stargazin [N245/1R]	177521	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Bassoon [L124/59R]	177470	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Pan-Shank [N23B/49R]	128637	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-SAP97 [K64/15R]	128624	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Shank2 [N23B/6R]	177519	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Shank1 [N22/21R]	177516	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-SAPAP3 [L126/93R]	177473	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GluN1 [N308/48R]	177529	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GluA2 [L21/32R]	177480	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-PSD-95 [K28/74R]	177439	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
HC25 pComb3xss anti-Homer1 nanobody	134718	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R]	177570	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Neuroligin-3 [N110/29.4R]	114518	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Shank3 [N69/46R]	140078	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
SS1 pComb3xss anti-SAPAP2 nanobody	145818	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Pan-SAPAP [N127/31.1R]	114529	Mingjie Zhang	4/27/2022	Hong Kong University of Science and Technology	HK
Anti-Copper ATPase 1 (Menke's disease protein) [L60/4R]	114502	Huadong Pei	4/25/2022	Georgetown University	US
Anti-GFP [N86/38.1R]	114492	Long Feng	4/19/2022	Wuhan University	CN
Anti-Nav1.1 Na+ channel [K74/71R] (Recombinant Antibody)	180089-rAb	Gemma Carvill	4/18/2022	Northwestern University	US
Anti-GFP [N86/38.1R]	114492	Christopher Westlake	4/14/2022	National Cancer Institute (NCI)	US
Anti-WAVE1/SCAR [K91/36R]	128629	Christopher Westlake	4/14/2022	National Cancer Institute (NCI)	US
Anti-DNAH7 [N250/21.4R]	164158	Christopher Westlake	4/14/2022	National Cancer Institute (NCI)	US
GluN2B/NR2B glutamate receptor scFv [N59/20]	182092	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GluN1 [N308/48R]	177529	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GluN2A [N327/95R]	177531	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
GluN2B/NR2B glutamate receptor scFv [N59/36]	182093	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GluN2A [N327A/38R]	177532	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
Anti-SynDIG4/Prrt1 [L102/45R]	177450	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
Anti-NrCAM [N343/26R]	177534	Matthew Kennedy	4/13/2022	University of Colorado Denver and Anschutz Medical Campus	US
S1-54 pComb3xss anti-cFos nanobody	145836	Jie wen	4/13/2022	University of Science and Technology of China	CN
S1-71 pComb3xss anti-cFos nanobody	145832	Jie wen	4/13/2022	University of Science and Technology of China	CN
C1-62 pComb3xss anti-cFos nanobody	145835	Jie wen	4/13/2022	University of Science and Technology of China	CN
C2-66 pComb3xss anti-cFos nanobody	145833	Jie wen	4/13/2022	University of Science and Technology of China	CN
C2-58 pComb3xss anti-cFos nanobody	145831	Jie wen	4/13/2022	University of Science and Technology of China	CN
C1-84 pComb3xss anti-cFos nanobody	145830	Jie wen	4/13/2022	University of Science and Technology of China	CN
C2-77 pComb3xss anti-cFos nanobody	145837	Jie wen	4/13/2022	University of Science and Technology of China	CN
S2-77 pComb3xss anti-cFos nanobody	145834	Jie wen	4/13/2022	University of Science and Technology of China	CN
C2-82 pComb3xss anti-cFos nanobody	145838	Jie wen	4/13/2022	University of Science and Technology of China	CN
C1-82 pComb3xss anti-cFos nanobody	145829	Jie wen	4/13/2022	University of Science and Technology of China	CN
Anti-MMP9 matrix metalloproteinase-9 precursor [L51/82R]	149455	Leonid Chernomordik	4/12/2022	National Institute of Child Health and Human Development (NICHD)	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Paul G Ahlquist	4/11/2022	Morgridge Institute for Research	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody)	180093-rAb	Peng Zhang	4/8/2022	Case Western Reserve University	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody)	180087-rAb	Peng Zhang	4/8/2022	Case Western Reserve University	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Peng Zhang	4/8/2022	Case Western Reserve University	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	Peng Zhang	4/8/2022	Case Western Reserve University	US
Anti-GFP [N86/38.1R] (Recombinant Antibody trial size)	180084-rAb.T	Matthew Lalli	4/6/2022	Icahn School of Medicine at Mount Sinai	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody trial size)	180082-rAb.T	Matthew Lalli	4/6/2022	Icahn School of Medicine at Mount Sinai	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody trial size)	180082-rAb.T	Beth Stevens	4/6/2022	Boston Children's Hospital	US
Bassoon scFv [L124/59]	182078	Paul Selvin	4/5/2022	University of Illinois at Urbana-Champaign	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Stanley Thomas Carmichael	4/4/2022	University of California, Los Angeles (UCLA)	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody)	180087-rAb	Stanley Thomas Carmichael	4/4/2022	University of California, Los Angeles (UCLA)	US
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Randy Schekman	4/4/2022	University of California, Berkeley	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Francis Lynn	4/4/2022	University of British Columbia	CA
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	JÃ¼rgen Klingauf	4/4/2022	Universitaetsklinikum Muenster	DE
IRSp53/BAIAP2 scFv [L117/1]	182075	JÃ¼rgen Klingauf	4/4/2022	Universitaetsklinikum Muenster	DE
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Hitoshi Shimano	4/3/2022	University of Tsukuba	JP
Anti-VGlut1 [N28/9R] (Recombinant Antibody trial size)	180087-rAb.T	Hongjun Song	4/1/2022	University of Pennsylvania	US
SS41 pComb3xss anti-SAPAP2 nanobody	145823	Min Sun Kim	3/31/2022	Kongju National University	KR
Anti-Kv4.2 K+ channel [L28/4R] (Recombinant Antibody)	180107-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Cav3.1 Ca2+ channel [N178A/9.1R] (Recombinant Antibody)	180106-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-PSD-95 [K28/43R] (Recombinant Antibody)	180082-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-SynCAM4 [N244/5R] (Recombinant Antibody)	180105-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Navbeta4 Na+ channel [N168/6.3R] (Recombinant Antibody)	180111-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-TRIP8b (constant) [N212/17R] (Recombinant Antibody)	180109-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv2.1 K+ channel (External) [K39/25R] (Recombinant Antibody)	180104-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Ataxin-1, 11NQ [N76/8R] (Recombinant Antibody)	180116-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-VGlut2 [N29/29R] (Recombinant Antibody)	180099-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-MMP9 precursor [L51/82R] (Recombinant Antibody)	180110-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-SUR1 [N289/16R] (Recombinant Antibody)	180113-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Iduna/RNF146 [N201/35R] (Recombinant Antibody)	180112-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R] (Recombinant Antibody)	180102-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Arl13b [N295B/66R] (Recombinant Antibody)	180085-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-HCN4 [N114/10.1R] (Recombinant Antibody)	180096-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-VGlut1 [N28/9R] (Recombinant Antibody)	180087-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R] (Recombinant Antibody)	180093-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-RGS14 [N133/21.2R] (Recombinant Antibody)	180088-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Neuroligin-1 [N97A/31R] (Recombinant Antibody)	180094-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-HCN1 [N70/28R] (Recombinant Antibody)	180092-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Nav1.1 Na+ channel [K74/71R] (Recombinant Antibody)	180089-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv2.1 K+ channel [K89/34R] (Recombinant Antibody)	180083-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv4.3 K+ channel [K75/41R] (Recombinant Antibody)	180097-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.1 K+ channel [K20/78R] (Recombinant Antibody)	180098-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Mortalin/GRP75 [N52A/42.1R] (Recombinant Antibody)	180091-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-Kv1.2 K+ channel [K14/16R] (Recombinant Antibody)	180086-rAb	Zhuhao Wu	3/29/2022	Icahn School of Medicine at Mount Sinai	US
Anti-GFP [N86/38.1R] (Recombinant Antibody)	180084-rAb	Hesso Farhan	3/28/2022	Innsbruck Medical University, Austria	AT
Anti-GFP [N86/38.1R]	114492	Byung Joon Hwang	3/24/2022	Kangwon National University	KR
Anti-Neuregulin-HBD (Heparin binding domain, Type I/II) [N120A/9.1R]	114507	Azeddine Atfi	3/17/2022	Virginia Commonwealth University	US
Anti-6xHis [N144/14R]	177500	Azeddine Atfi	3/17/2022	Virginia Commonwealth University	US
Anti-GFP [N86/38.1R]	114492	Andrew Tsourkas	3/15/2022	University of Pennsylvania	US
Anti-Kv7.2/KCNQ2 K+ channel [N26A/23R]	177524	William Renthal	3/10/2022	Brigham and Women's Hospital	US
Anti-GAD67 [L127/8R]	177475	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Alpha1 [N95/35R]	177574	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Beta3 [N87/25R]	177573	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GAD65/67 [L127/12R]	177474	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
GC1 pComb3xss anti-Gephyrin nanobody	134720	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-PSD-95 [K28/43R]	128618	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Alpha2 [N399/19R]	177544	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-Collybistin [L120/12R]	177575	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-VGlut2 [N29/29R]	114501	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Alpha5 [N415/24R]	149456	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Gamma2L [N452/81R]	177554	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Gamma2L/S [N452/73R]	177553	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-Collybistin [L120/30R]	177465	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-VGlut1 [N28/9R]	128638	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-GABA(A)R, Beta1 [N96/55.3R]	114549	Mingjie Zhang	3/10/2022	Hong Kong University of Science and Technology	HK
Anti-Lgi1 [N283/7R]	177527	Prof. Dr. Jan LÃ¼nemann	3/9/2022	Universitaetsklinikum Muenster	DE
Anti-GFP [N86/38.1R]	114492	Schara Safarian	3/8/2022	Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)	DE
Anti-GFP [N86/8R]	177572	Schara Safarian	3/8/2022	Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)	DE
C1-82 pComb3xss anti-cFos nanobody	145829	Schara Safarian	3/8/2022	Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)	DE
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
AC50 pEGFPN1 anti-AMIGO-1 nanobody	135225	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
AC27 pEGFPN1 anti-AMIGO-1 nanobody	135226	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
HS22 pEYFPN1 anti-Homer1 nanobody	135219	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
HS38 pEYFPN1 anti-Homer1 nanobody	135221	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Uri Manor	3/7/2022	Salk Institute for Biological Studies	US
Anti-Pan-Synapsin [L125/129R]	177472	Kazuhisa Kohda	3/3/2022	St. Marianna University School of Medicine	JP
Anti-GABA(A)R, alpha6 [N229A/32R]	164155	Kazuhisa Kohda	3/3/2022	St. Marianna University School of Medicine	JP
Anti-GABA(B)R2 [N81/37.1R]	114544	Xin Tang	3/2/2022	Boston Children's Hospital	US
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	Xin Tang	3/2/2022	Boston Children's Hospital	US
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Prof. Volker Haucke	2/23/2022	Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie	DE
Anti-SK2 K+ channel [K78/29R]	177448	Miao Zhang	2/22/2022	Chapman University	US
Anti-6xHis [N144/14R]	177500	Dr. Ahmad Fawzi Hussain	2/17/2022	Justus Liebig-Universitaet Giessen	DE
AC50 pEGFPN1 anti-AMIGO-1 nanobody	135225	Carlos Rosado	2/16/2022	Monash University	AU
AC27 pEGFPN1 anti-AMIGO-1 nanobody	135226	Carlos Rosado	2/16/2022	Monash University	AU
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Isabel PÃ©rez-OtaÃ±o	2/15/2022	Instituto de Neurociencias de Alicante	ES
Anti-GFP [N86/38.1R]	114492	Louis Falo	2/14/2022	University of Pittsburgh (University, School of Medicine, and Cancer Institute)	US
Anti-GFP [N86/38.1R]	114492	Urartu Seker	2/10/2022	Bilkent University UNAM, Nanotechnology Research Center	TR
Anti-6xHis [N144/14R]	177500	Urartu Seker	2/10/2022	Bilkent University UNAM, Nanotechnology Research Center	TR
C1-82 pComb3xss anti-cFos nanobody	145829	Hartmut Michel	2/10/2022	Max Planck Institute of Biophysics	DE
Anti-GFP [N86/38.1R]	114492	Hartmut Michel	2/10/2022	Max Planck Institute of Biophysics	DE
Anti-GFP [N86/8R]	177572	Hartmut Michel	2/10/2022	Max Planck Institute of Biophysics	DE
Anti-GIT1 [N39B/8R]	177545	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-WAVE1/SCAR [K91/36R]	128629	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-Shank3 [N69/46R]	140078	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-Tiam1 [L130/1R]	177476	Takeo Saneyoshi	2/7/2022	Kyoto University, Graduate School of Medicine	JP
Anti-SAP97 [K64/15R]	128624	Prof. Dr. Markus Missler	1/31/2022	Universitaetsklinikum Muenster	DE
Anti-PSD-95 [K28/43R]	128618	Douglas Houston	1/27/2022	University of Iowa	US
Anti-VDAC1 [N152B/23R]	177502	Marco Lolicato	1/27/2022	Universita degli Studi di Pavia	IT
Anti-6xHis [N144/14R]	177500	Dieter Edbauer	1/24/2022	Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)	DE
Anti-GFP [N86/38.1R]	114492	Dieter Edbauer	1/24/2022	Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)	DE
Anti-ASIC1 [N271/44R]	177525	David MacLean	1/20/2022	University of Rochester Medical Center	US
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R]	177486	Roderick MacKinnon	1/14/2022	Rockefeller University	US
Anti-GluK5/Grik5/KA2 kainate receptor [N279B/27R]	149451	Nami Tajima	1/14/2022	Case Western Reserve University	US
Anti-Shank3 [N69/46R]	140078	Sanford Shattil	1/13/2022	University of California, San Diego (UCSD)	US
Anti-6xHis [N144/14R]	177500	Prof. G. Schwarz	1/12/2022	Universitaet zu Koeln	DE
Anti-VGAT [L118/80R]	177463	Prof. G. Schwarz	1/12/2022	Universitaet zu Koeln	DE
Anti-PSD-95 [K28/43R]	128618	Prof. G. Schwarz	1/12/2022	Universitaet zu Koeln	DE
Anti-c-Fos [N486/32R]	177559	Prof. G. Schwarz	1/12/2022	Universitaet zu Koeln	DE
Anti-Collybistin [L120/12R]	177575	Prof. G. Schwarz	1/12/2022	Universitaet zu Koeln	DE
Anti-FGF12/FHF1 [N94/17R]	114538	Pierre Vanderhaeghen	1/7/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-Pan-FHF-A [N235/22R]	114509	Pierre Vanderhaeghen	1/7/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-FGF13/FHF2 [N91/27.1R]	114525	Pierre Vanderhaeghen	1/7/2022	Vlaams Instituut voor Biotechnologie (VIB, vzw)	BE
Anti-PSD-95 [K28/43R]	128618	Jinghua Wang	1/6/2022	Harbin Medical University	CN
Anti-Parvalbumin [L114/3R]	177459	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-SK2 K+ channel [K78/29R]	177448	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Calbindin [L109/39R]	177454	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-VIP [L108/92R]	177453	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-GFAP [N206A/8R]	177512	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Kir6.2 K+ channel [N363/71R]	177535	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-NPY [L115/13R]	177461	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R]	177486	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Dopamine D2 receptor [N186/29R]	177509	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-VGlut1 [N28/9R]	128638	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Calbindin [L109/57R]	177455	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-c-Fos [N486/32R]	177559	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-Parvalbumin [L114/81R]	177460	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-GAD67 [L127/8R]	177475	Elias Leiva	1/4/2022	Universidad de Santiago de Chile	CL
Anti-GFP [N86/38.1R]	114492	Sue Biggins	12/20/2021	Fred Hutchinson Cancer Center	US
Anti-Synaptotagmin-3 [N278/19R]	114476	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-GABA(A)R, Alpha1 [N95/35R]	177574	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Nav1.7 Na+ channel [N68/6R]	177566	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-mGluR1/5 (Group I) glutamate receptor [N75/33R]	177570	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Cav1.3 Ca2+ channel [N38/8R]	177540	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-S100A5 [N176A/35.1R]	114560	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-VIP [L108/92R]	177453	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Kv2.1 K+ channel [L83/11R]	177490	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Kv1.2 K+ channel [L76/36R]	177489	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Kv2.1 K+ channel [L61C/30R]	177487	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Slo1/BKAlpha maxi-K+ channel [L6/60R]	177486	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Cav1.2/1.3 Ca2+ channel [L57/46R]	177485	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-TrpV1 [N221/17R]	177517	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Pan-Synapsin [L125/129R]	177472	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Brevican [N294A/10R]	177528	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-NPY [L115/13R]	177461	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Parvalbumin [L114/81R]	177460	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Homer1L [L113/27R]	177458	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Beta4-spectrin [N393/2R]	177541	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Dopamine D3 receptor [N331/19R]	114488	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Kv3.2 K+ channel [N410/17R]	177548	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-NCKX4 [N414/25R]	177549	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Neuroligin-2 [L107/39R]	177452	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-c-Fos [N486/32R]	177559	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-SK2 K+ channel [K78/29R]	177448	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-c-Fos [N486/76R]	177560	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-CASPR2 [K67/25R]	177446	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
Anti-Cav3.2 Ca2+ channel [N55/10R]	177562	Gurkan Ozturk	12/9/2021	Istanbul Medipol University	TR
K51/1RAnti-SH3GL1/Endophilin A2 [K51/1R]	128621	Jorg Grandl	11/29/2021	Duke University	US
Anti-GFAP [N206A/8R]	177512	Prof. Dr. Stefan PÃ¶hlmann	11/26/2021	Deutsches Primatenzentrum (DPZ)	DE
Anti-Contactin/F3 [K73/20R]	177447	Dies Meijer	11/18/2021	University of Edinburgh	GB
Anti-CASPR2 [K67/25R]	177446	Dies Meijer	11/18/2021	University of Edinburgh	GB
Anti-CASPR/Neurexin IV [K65/35R]	177445	Dies Meijer	11/18/2021	University of Edinburgh	GB
Anti-CASPR2 [K67/25R]	177446	Jerome Devaux	11/18/2021	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-Contactin/F3 [K73/20R]	177447	Jerome Devaux	11/18/2021	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-CASPR/Neurexin IV [K65/35R]	177445	Jerome Devaux	11/18/2021	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-TRIP8b (exon 4) [N212/3R]	114473	Yoshinori Fujiyoshi	11/14/2021	Tokyo Medical and Dental University	JP
Anti-Mitofusin-2 [N153/5.1R]	114547	Mansoor Amiji	11/10/2021	Northeastern University	US
Anti-Ankyrin-R [N388A/10R]	114479	Yuxin Yin	11/8/2021	Peking University	CN
Anti-Ankyrin-G (staining) [N106/43R]	128635	Oscar Cerda	10/31/2021	Universidad de Chile	CL
Anti-Arl13b [N295B/66R]	140076	Serhiy Havrylov	10/29/2021	University of Alberta	CA
Anti-GABA(A)R, Alpha5 [N415/24R]	149456	Sila Ultanir	10/26/2021	Francis Crick Institute	GB
C1-82 pComb3xss anti-cFos nanobody	145829	Samuel Rodriques	10/25/2021	Francis Crick Institute	GB
Anti-BK beta4 K+ channel [L18A/3R]	149454	Roderick MacKinnon	10/22/2021	Rockefeller University	US
Anti-Slo1/BKAlpha maxi-K+ channel (Mouse) [L6/23R]	128634	Roderick MacKinnon	10/22/2021	Rockefeller University	US
Anti-Ankyrin-G (staining) [N106/43R]	128635	Stanley Thomas Carmichael	10/12/2021	University of California, Los Angeles (UCLA)	US
C2-66 pComb3xss anti-cFos nanobody	145833	Anna Leopold	10/11/2021	University of Helsinki, Institute of Biomedicine	FI
Anti-PSD-95 [K28/43R]	128618	Masaki Fukata	9/29/2021	National Institute for Physiological Sciences	JP
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Masaki Fukata	9/29/2021	National Institute for Physiological Sciences	JP
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Axel T Brunger	9/22/2021	Stanford University	US
HC87 pEYFPN1 anti-Homer1 nanobody	135223	James Jontes	9/22/2021	Ohio State University	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	James Jontes	9/22/2021	Ohio State University	US
Anti-SAP97 [K64/15R]	128624	DRA. MARCELA LIZANO SOBERON	9/7/2021	Universidad Nacional Autonoma de Mexico	MX
Anti-GFAP R416WT [N206B/9R]	114536	Prof. Dr. Gurkan Ozturk	9/6/2021	Istanbul Medipol University	TR
Anti-GFP [N86/38.1R]	114492	Prof. Dr. Gurkan Ozturk	9/6/2021	Istanbul Medipol University	TR
Anti-Pannexin-2 [N121A/31R]	140073	Prof. Dr. Gurkan Ozturk	9/6/2021	Istanbul Medipol University	TR
Anti-PSD-95 [K28/43R]	128618	Prof. Dr. Gurkan Ozturk	9/6/2021	Istanbul Medipol University	TR
Anti-MMP9 matrix metalloproteinase-9 precursor [L51/82R]	149455	Prof. Dr. Gurkan Ozturk	9/6/2021	Istanbul Medipol University	TR
Anti-SAP97 [K64/15R]	128624	Jinghua Wang	9/2/2021	Harbin Medical University	CN
Anti-Kv1.6 K+ channel [K19/36R]	140068	John Lewis	8/31/2021	University of Alberta	CA
Anti-WAVE1/SCAR [K91/36R]	128629	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-VGlut1 [N28/9R]	128638	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Ankyrin-G (staining) [N106/43R]	128635	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-SynDIG1/Tmem90b [L42/17R]	128632	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-PICK1 [L20/8R]	128630	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Kvbeta1.1/KCNAB1 K+ channel [K9/40R]	140070	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Synaptotagmin-3 [N278/19R]	114476	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Kv1.1 K+ channel [K20/78R]	128616	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Nav1.1 Na+ channel [K74/71R]	128626	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-JIP-2/IB-2 [N135/37.2R]	114527	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Flrt3 [N353/13R]	114486	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Doc2b [N150/21.3R]	114516	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-SNAT1 [N104/32.1R]	114517	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Neuroligin-3 [N110/29.4R]	114518	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Neurexin-1-Beta [N170A/1.1R]	114530	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-PSD-95 [K28/43R]	128618	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GFAP R416WT [N206B/9R]	114536	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GABA(B)R2 [N81/37.1R]	114544	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Neuroligin-1 [N97A/31R]	114554	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-SynCAM4 [N244/5R]	114562	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Kv1.4 K+ channel [K13/31R]	128613	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Snapin/SNAPAP [L8/15R]	140071	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Gamma-protocadherin-C3 [N174B/27R]	164156	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Kirrel3, short isoform 3 [N320/48R]	149452	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Shank3 [N69/46R]	140078	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GIT2 [N83/48R]	140079	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-Neuroligin-4* [N98/7R]	140081	Naoki Watanabe	8/30/2021	Kyoto University, Graduate School of Medicine	JP
Anti-GFP [N86/38.1R]	114492	Yoshimasa Kawaguchi	8/24/2021	Kyoto University, Institute for Chemical Research	JP
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Maxine Rebstadt	7/29/2021	Monash University	AU
HS69 pComb3xss anti-Homer1 nanobody	134716	Paul Selvin	7/28/2021	University of Illinois at Urbana-Champaign	US
Anti-Kv1.6 K+ channel [K19/36R]	140068	Le Cong	7/26/2021	Stanford University	US
Anti-S100A5 [N176A/35.1R]	114560	Oscar Cerda	7/21/2021	Universidad de Chile	CL
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Oscar Cerda	7/21/2021	Universidad de Chile	CL
Anti-GFP [N86/38.1R]	114492	Oscar Cerda	7/21/2021	Universidad de Chile	CL
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Santhosh Kumar T.R	7/7/2021	Rajiv Gandhi Centre for Biotechnology	IN
Anti-GFP [N86/38.1R]	114492	Santhosh Kumar T.R	7/7/2021	Rajiv Gandhi Centre for Biotechnology	IN
Anti-GFP [N86/38.1R]	114492	Paul Young	7/6/2021	University College Cork	IE
Anti-MMP9 matrix metalloproteinase-9 precursor [L51/82R]	149455	Prof. Dr. Markus Missler	6/30/2021	Universitaetsklinikum Muenster	DE
Anti-Neuroligin-1 [N97A/31R]	114554	Prof. Dr. Markus Missler	6/30/2021	Universitaetsklinikum Muenster	DE
Anti-LRRTM4 [N205B/22R]	128636	Prof. Dr. Markus Missler	6/30/2021	Universitaetsklinikum Muenster	DE
Anti-Neurexin-1-Beta [N170A/1.1R]	114530	Prof. Dr. Markus Missler	6/30/2021	Universitaetsklinikum Muenster	DE
Anti-GFP [N86/38.1R]	114492	Prof. Dr. Markus Missler	6/30/2021	Universitaetsklinikum Muenster	DE
Anti-GFP [N86/38.1R]	114492	Zachary C. Hartman	6/28/2021	Duke University	US
Anti-GFP [N86/38.1R]	114492	Carrie Doonan	6/28/2021	Carnegie Mellon University	US
Anti-GFP [N86/38.1R]	114492	Narendrakumar Ramanan	6/25/2021	Indian Institute of Science, Bangalore	IN
Anti-PSD-95 [K28/43R]	128618	Narendrakumar Ramanan	6/25/2021	Indian Institute of Science, Bangalore	IN
Anti-GFAP R416WT [N206B/9R]	114536	Narendrakumar Ramanan	6/25/2021	Indian Institute of Science, Bangalore	IN
Anti-Arl13b [N295B/66R]	140076	PI - WESTLAKE	6/24/2021	National Cancer Institute (NCI)	US
Anti-Pan-Ankyrin [N388A/60R]	128640	jÃ©rÃ´me Devaux	6/18/2021	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-Ankyrin-G (staining) [N106/43R]	128635	jÃ©rÃ´me Devaux	6/18/2021	INSERM U1191, Institut de GÃ©nomique Fonctionnelle  (IGF)	FR
Anti-GFP [N86/38.1R]	114492	Min Jae Lee	6/15/2021	Seoul National University	KR
Anti-Ankyrin-G (staining) [N106/43R]	128635	Min Jae Lee	6/15/2021	Seoul National University	KR
Anti-GFP [N86/38.1R]	114492	Ramon Tasan	6/9/2021	Innsbruck Medical University, Austria	AT
Anti-GFP [N86/38.1R]	114492	Harald Illges	5/28/2021	Hochschule Bonn-Rhein-Sieg	DE
Anti-Shank3 [N69/46R]	140078	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-Cavbeta1 Ca2+ channel [N7/18.1R]	114497	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-PSD-95 [K28/43R]	128618	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-Pan-Shank [N23B/49R]	128637	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-Cavbeta2 Ca2+ channel [N8B/1R]	149458	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Sanduo Zheng	5/28/2021	National Institute of Biological Sciences, Beijing	CN
Anti-GFP [N86/38.1R]	114492	Dr Bernard Couvreur	5/27/2021	Culture in vivo ASBL	BE
Anti-Mitofusin-2 [N153/5.1R]	114547	Michael Sheetz	5/14/2021	University of Texas Medical Branch at Galveston	US
Anti-Mitofusin-1 [N111/24R]	140072	Michael Sheetz	5/14/2021	University of Texas Medical Branch at Galveston	US
Anti-PSD-95 [K28/43R]	128618	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-Pan-Nav1 Na+ channel [N419/78R]	114553	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-VGlut1 [N28/9R]	128638	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-GABA(B)R1 [N93A/49.2R]	114550	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-Mitofusin-1 [N111/24R]	140072	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-GFAP R416WT [N206B/9R]	114536	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Kang-Sik Park	5/4/2021	Kyung Hee University	KR
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Kay Gruenewald	4/27/2021	Leibniz-Institut fuer Virologie (LIV	DE
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Yasunori Hayashi	4/13/2021	Kyoto University, Graduate School of Medicine	JP
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Yasunori Hayashi	4/13/2021	Kyoto University, Graduate School of Medicine	JP
HC25 pComb3xss anti-Homer1 nanobody	134718	Yasunori Hayashi	4/13/2021	Kyoto University, Graduate School of Medicine	JP
C2-77 pComb3xss anti-cFos nanobody	145837	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C1-84 pComb3xss anti-cFos nanobody	145830	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
S2-77 pComb3xss anti-cFos nanobody	145834	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
HS69 pComb3xss anti-Homer1 nanobody	134716	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
HC25 pComb3xss anti-Homer1 nanobody	134718	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C1-62 pComb3xss anti-cFos nanobody	145835	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
GC1 pComb3xss anti-Gephyrin nanobody	134720	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C2-58 pComb3xss anti-cFos nanobody	145831	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
S1-54 pComb3xss anti-cFos nanobody	145836	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
S1-71 pComb3xss anti-cFos nanobody	145832	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C1-82 pComb3xss anti-cFos nanobody	145829	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C2-66 pComb3xss anti-cFos nanobody	145833	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
C2-82 pComb3xss anti-cFos nanobody	145838	Xu Fang	4/9/2021	Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences	CN
S1-54 pComb3xss anti-cFos nanobody	145836	Hiroki R. Ueda	4/1/2021	RIKEN Center for Biosystems Dynamics Research	JP
C1-84 pComb3xss anti-cFos nanobody	145830	Hiroki R. Ueda	4/1/2021	RIKEN Center for Biosystems Dynamics Research	JP
C2-82 pComb3xss anti-cFos nanobody	145838	Hiroki R. Ueda	4/1/2021	RIKEN Center for Biosystems Dynamics Research	JP
S2-77 pComb3xss anti-cFos nanobody	145834	Hiroki R. Ueda	3/31/2021	RIKEN Center for Biosystems Dynamics Research	JP
C2-82 pComb3xss anti-cFos nanobody	145838	Hiroki R. Ueda	3/31/2021	RIKEN Center for Biosystems Dynamics Research	JP
C1-82 pComb3xss anti-cFos nanobody	145829	Hiroki R. Ueda	3/31/2021	RIKEN Center for Biosystems Dynamics Research	JP
Anti-Arl13b [N295B/66R]	140076	Yongku Cho	3/29/2021	University of Connecticut	US
Anti-PSD-95 [K28/43R]	128618	Francisco Javier DIEZ GUERRA	3/12/2021	Centro de Biologia Molecular Severo Ochoa	ES
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Maxine Rebstadt	3/9/2021	Monash University	AU
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-Versican [N351/23R]	128639	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-Pan-Nav channel [K58/35R]	128623	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-Pan-Ankyrin [N388A/60R]	128640	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-Neuroligin-1 [N97A/31R]	114554	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-Pan-Kvbeta K+ channel [K25/73R]	128617	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-SynCAM4 [N244/5R]	114562	Manuel Koch	3/9/2021	Uniklinik Koeln	DE
Anti-GFP [N86/38.1R]	114492	Prof. Martin Biel	3/5/2021	Ludwig-Maximilians-Universitaet Muenchen (LMU)	DE
Anti-GFP [N86/38.1R]	114492	Stylianos Michalakis	3/5/2021	Ludwig-Maximilians-Universitaet Muenchen (LMU)	DE
Anti-LRP4 (cytoplasmic) [N164/6.1R]	114542	Federico Forneris	3/2/2021	Universita degli Studi di Pavia	IT
Anti-LRRTM4 [N205B/22R]	128636	Federico Forneris	3/2/2021	Universita degli Studi di Pavia	IT
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Tobias Bonhoeffer	3/2/2021	Max Planck Institute of Neurobiology	DE
Anti-HCN4 [N114/10.1R]	114506	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-HCN1 [N70/28R]	114512	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-GFP [N86/38.1R]	114492	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Kv1.1 K+ channel (External) [K36/15R]	128619	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Nav1.1 Na+ channel [K74/71R]	128626	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Kv4.2 K+ channel [L28/4R]	149453	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
Anti-Ankyrin-G (staining) [N106/43R]	128635	Elias Leiva	2/26/2021	Universidad de Santiago de Chile	CL
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Jennifer Lippincott-Schwartz	2/24/2021	HHMI, Janelia Research Campus	US
Anti-Kv1.1 K+ channel (External) [K36/15R]	128619	Patrick Swanson	2/23/2021	Creighton University	US
Anti-Kv4.2 K+ Channel (External) [K57/1R]	128622	Bernd Fakler	2/17/2021	Albert-Ludwigs-Universitaet Freiburg	DE
Anti-Kv4.2 K+ channel [L28/4R]	149453	Bernd Fakler	2/17/2021	Albert-Ludwigs-Universitaet Freiburg	DE
Anti-GABA(A)R, Epsilon [N413/67R]	114478	Brian Young	2/12/2021	University of San Francisco	US
Anti-GFP [N86/38.1R]	114492	Lorenza Penengo	2/11/2021	University of Zurich	CH
Anti-GFP [N86/38.1R]	114492	Shinsuke Niwa	1/27/2021	Tohoku University, Frontier Research Institute for Interdisciplinary Sciences	JP
Anti-GFAP R416WT [N206B/9R]	114536	Timm Schroeder	1/27/2021	ETH Zurich (Swiss Federal Institute of Technology)	CH
Anti-Arl13b [N295B/66R]	140076	Timm Schroeder	1/27/2021	ETH Zurich (Swiss Federal Institute of Technology)	CH
Anti-GFP [N86/38.1R]	114492	Timm Schroeder	1/27/2021	ETH Zurich (Swiss Federal Institute of Technology)	CH
Anti-GFP [N86/38.1R]	114492	Patricia K. Donahoe	1/22/2021	Massachusetts General Hospital	US
Anti-GFP [N86/38.1R]	114492	David Pepin	1/22/2021	Massachusetts General Hospital	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Raphael Gaudin	1/12/2021	CNRS, Delegation Occitanie Est	FR
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Raphael Gaudin	1/12/2021	CNRS, Delegation Occitanie Est	FR
Anti-SUR1 [N289/16R]	114556	QING ZHONG	12/30/2020	Shanghai Jiaotong University, School of Medicine	CN
Anti-GFP [N86/38.1R]	114492	Jerzy Szablowski	12/29/2020	Rice University	US
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Paul Selvin	12/11/2020	University of Illinois at Urbana-Champaign	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Paul Selvin	12/11/2020	University of Illinois at Urbana-Champaign	US
Anti-Arl13b [N295B/66R]	140076	Kazuhisa Nakayama	11/25/2020	Kyoto University, Graduate School of Pharmaceutical Sciences	JP
Anti-VGlut2 [N29/29R]	114501	Prof. Avraham Yaron	11/18/2020	Weizmann Institute of Science	IL
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Kenton Swartz	11/16/2020	National Institute of Neurological Disorders and Strokes (NINDS)	US
Anti-TRPML3/Mucolipin-3 [N268/19R]	114477	Kenton Swartz	11/16/2020	National Institute of Neurological Disorders and Strokes (NINDS)	US
Anti-Kv2.1 K+ Channel [D3/71R]	128612	Kenton Swartz	11/16/2020	National Institute of Neurological Disorders and Strokes (NINDS)	US
Anti-Shank3 [N69/46R]	140078	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-GFAP R416WT [N206B/9R]	114536	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-VGlut2 [N29/29R]	114501	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-VGlut3 [N34/34.2R]	114494	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
HS63 pComb3xss anti-Homer1 nanobody	134715	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-Neuregulin-HBD (Heparin binding domain, Type I/II) [N120A/9.1R]	114507	Pietro Fazzari	11/12/2020	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-GFAP R416WT [N206B/9R]	114536	Ming-Der Perng	11/9/2020	National Tsing Hua University	TW
GC92 pComb3xss anti-Gephyrin nanobody	145826	Sudha Chakrapani	11/8/2020	Case Western Reserve University	US
Anti-GFP [N86/38.1R]	114492	Kang-Sik Park	11/3/2020	Kyung Hee University	KR
Anti-GFAP R416WT [N206B/9R]	114536	Kang-Sik Park	11/3/2020	Kyung Hee University	KR
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	Kang-Sik Park	11/3/2020	Kyung Hee University	KR
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Kang-Sik Park	11/3/2020	Kyung Hee University	KR
Anti-PSD-95 [K28/43R]	128618	Kang-Sik Park	11/3/2020	Kyung Hee University	KR
Anti-GFP [N86/38.1R]	114492	Avraham Yaron	10/29/2020	Weizmann Institute of Science	IL
Anti-Snapin/SNAPAP [L8/15R]	140071	Thierry Galli	10/12/2020	Delegation INSERM Paris 5	FR
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Junichi Ikenouchi	9/29/2020	Kyushu University	JP
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Junichi Ikenouchi	9/29/2020	Kyushu University	JP
Anti-Pan-Nav channel [K58/35R]	128623	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-LRRTM4 [N205B/22R]	128636	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-KChIP3/DREAM [K66/38R]	128625	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-Ankyrin-G (staining) [N106/43R]	128635	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-Kv2.1 K+ Channel [D3/71R]	128612	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-Shank3 [N69/46R]	140078	Nathalie Sans	9/16/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-Neurexin-1-Beta [N170A/1.1R]	114530	Battefeld	9/4/2020	University of Bordeaux	FR
Anti-Ankyrin-G (staining) [N106/43R]	128635	Battefeld	9/4/2020	University of Bordeaux	FR
Anti-TRIP8b (constant) [N212/17R]	114557	Battefeld	9/4/2020	University of Bordeaux	FR
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Battefeld	9/4/2020	University of Bordeaux	FR
Anti-Slo1/BKAlpha maxi-K+ channel (Mouse) [L6/23R]	128634	Per Svenningsen	8/19/2020	University of Southern Denmark	DK
HS69 pComb3xss anti-Homer1 nanobody	134716	Andrew Todd	8/7/2020	University of Glasgow	GB
Anti-SynCAM4 [N244/5R]	114562	JÃ©rÃ´me Devaux	8/6/2020	INSERM U1298, Institut des Neurosciences de Montpellier (INM)	FR
Anti-Kv1.1 K+ channel [K20/78R]	128616	JÃ©rÃ´me Devaux	8/6/2020	INSERM U1298, Institut des Neurosciences de Montpellier (INM)	FR
Anti-Pan-Nav channel [K58/35R]	128623	JÃ©rÃ´me Devaux	8/6/2020	INSERM U1298, Institut des Neurosciences de Montpellier (INM)	FR
Anti-VGlut1 [N28/9R]	128638	Avraham Yaron	8/6/2020	Weizmann Institute of Science	IL
Anti-Ankyrin-G (staining) [N106/43R]	128635	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv1.1 K+ channel [K20/78R]	128616	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv2.1 K+ channel pS603 [L61/14R]	140063	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Mortalin/GRP75 [N52A/42.1R]	114548	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv2.1 K+ channel (External) [K39/25R]	128620	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Kang-Sik Park	8/6/2020	Kyung Hee University	KR
Anti-HCN4 [N114/10.1R]	114506	Gail Robertson	8/3/2020	University of Wisconsin, Madison	US
Anti-PSD-95 [K28/43R]	128618	Xie Yicheng	8/3/2020	Zhejiang University	CN
Anti-GFP [N86/38.1R]	114492	Xie Yicheng	8/3/2020	Zhejiang University	CN
Anti-GFAP R416WT [N206B/9R]	114536	Xie Yicheng	8/3/2020	Zhejiang University	CN
Anti-RGS14 [N133/21.2R]	114519	Anthony Rosenzweig	7/29/2020	Massachusetts General Hospital	US
Anti-PSD-95 [K28/43R]	128618	Zheng Junfeng	7/27/2020	Xinxiang Medical University	CN
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Zheng Junfeng	7/27/2020	Xinxiang Medical University	CN
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Zheng Junfeng	7/24/2020	Xinxiang Medical University	CN
Anti-PSD-95 [K28/43R]	128618	Zheng Junfeng	7/24/2020	Xinxiang Medical University	CN
Anti-GFP [N86/38.1R]	114492	Dies Meijer	7/20/2020	University of Edinburgh	GB
Anti-PSD-93/Chapsyn-110 [N18/30.1R]	114523	Dies Meijer	7/20/2020	University of Edinburgh	GB
Anti-GFAP R416WT [N206B/9R]	114536	Dies Meijer	7/20/2020	University of Edinburgh	GB
Anti-Kv1.6 K+ channel [K19/36R]	140068	Dies Meijer	7/20/2020	University of Edinburgh	GB
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R]	128615	Dies Meijer	7/20/2020	University of Edinburgh	GB
Anti-Mitofusin-2 [N153/5.1R]	114547	P Chandra Shekar	7/15/2020	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-Olig1 [N149/25.1R]	114540	P Chandra Shekar	7/15/2020	Centre for Cellular and Molecular Biology (CSIR-CCMB)	IN
Anti-GFP [N86/38.1R]	114492	Markus Sauer	7/15/2020	Julius-Maximilians-Universitaet Wuerzburg	DE
GS41 pComb3xss anti-Gephyrin nanobody	145828	Prof. G. Schwarz	7/9/2020	Universitaet zu Koeln	DE
C1-82 pComb3xss anti-cFos nanobody	145829	Ted Usdin	7/8/2020	National Institute of Mental Health (NIMH)	US
C1-62 pComb3xss anti-cFos nanobody	145835	Ted Usdin	7/8/2020	National Institute of Mental Health (NIMH)	US
C2-77 pComb3xss anti-cFos nanobody	145837	Ted Usdin	7/8/2020	National Institute of Mental Health (NIMH)	US
C1-84 pComb3xss anti-cFos nanobody	145830	Ted Usdin	7/8/2020	National Institute of Mental Health (NIMH)	US
C2-66 pComb3xss anti-cFos nanobody	145833	Ted Usdin	7/8/2020	National Institute of Mental Health (NIMH)	US
C2-77 pComb3xss anti-cFos nanobody	145837	Ted Usdin	7/7/2020	National Institute of Mental Health (NIMH)	US
C1-84 pComb3xss anti-cFos nanobody	145830	Ted Usdin	7/7/2020	National Institute of Mental Health (NIMH)	US
C2-66 pComb3xss anti-cFos nanobody	145833	Ted Usdin	7/7/2020	National Institute of Mental Health (NIMH)	US
C1-82 pComb3xss anti-cFos nanobody	145829	Ted Usdin	7/7/2020	National Institute of Mental Health (NIMH)	US
C1-62 pComb3xss anti-cFos nanobody	145835	Ted Usdin	7/7/2020	National Institute of Mental Health (NIMH)	US
Anti-SynCAM4 [N244/5R]	114562	Matthew Kennedy	6/30/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Matthew Kennedy	6/30/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-PSD-95 [K28/43R]	128618	Matthew Kennedy	6/30/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-Kv2.1 K+ channel (External) [K39/25R]	128620	Matthew Kennedy	6/30/2020	University of Colorado Denver and Anschutz Medical Campus	US
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Rafi Lamprecht	6/19/2020	Haifa University	IL
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Rafi Lamprecht	6/19/2020	Haifa University	IL
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Rafi Lamprecht	6/19/2020	Haifa University	IL
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Rafi Lamprecht	6/19/2020	Haifa University	IL
Anti-Flrt3 [N353/13R]	114486	Azeddine Atfi	6/18/2020	Virginia Commonwealth University	US
Anti-GFP [N86/38.1R]	114492	Azeddine Atfi	6/18/2020	Virginia Commonwealth University	US
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	MÂª Isabel Loza GarcÃ­a	6/17/2020	Universidad de Santiago de Compostela, Centro de Investigaciones Medicas 	ES
Anti-GFP [N86/38.1R]	114492	Alessandra Fucci	5/27/2020	Biogem SCARL, IRGS Instituto di ricerche genetiche Gaetano Salvatore	IT
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Mingshan Xue	5/21/2020	Baylor College of Medicine	US
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Mingshan Xue	5/21/2020	Baylor College of Medicine	US
Anti-GluN2B/NR2B glutamate receptor [N59/36.1R]	114508	Lars Ittner	4/22/2020	Macquarie University	AU
Anti-PSD-95 [K28/43R]	128618	Lars Ittner	4/22/2020	Macquarie University	AU
HS63 pComb3xss anti-Homer1 nanobody	134715	Jigang Wang	3/31/2020	Shenzhen People's Hospital	CN
Anti-Neurexin-1-Beta [N170A/1.1R]	114530	William N Green	3/26/2020	University of Chicago	US
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Kenzo Hirose	3/4/2020	University of Tokyo, Graduate School of Medicine	JP
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Kenzo Hirose	3/4/2020	University of Tokyo, Graduate School of Medicine	JP
GC1 pComb3xss anti-Gephyrin nanobody	134720	Prof. G. Schwarz	3/4/2020	Universitaet zu Koeln	DE
GC83 pComb3xss anti-Gephyrin nanobody	134721	Prof. G. Schwarz	3/4/2020	Universitaet zu Koeln	DE
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Prof. G. Schwarz	3/4/2020	Universitaet zu Koeln	DE
HS69 pComb3xss anti-Homer1 nanobody	134716	Stanley Thomas Carmichael	3/2/2020	University of California, Los Angeles (UCLA)	US
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Vladislav Verkhusha	2/29/2020	University of Helsinki, Institute of Biomedicine	FI
HS22 pEYFPN1 anti-Homer1 nanobody	135219	Vladislav Verkhusha	2/29/2020	University of Helsinki, Institute of Biomedicine	FI
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Vladislav Verkhusha	2/29/2020	University of Helsinki, Institute of Biomedicine	FI
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Vladislav Verkhusha	2/29/2020	University of Helsinki, Institute of Biomedicine	FI
AC27 pEGFPN1 anti-AMIGO-1 nanobody	135226	Vladislav Verkhusha	2/29/2020	University of Helsinki, Institute of Biomedicine	FI
Anti-GFP [N86/38.1R]	114492	Dr Jean-Claude Twizere	2/24/2020	Faculty of Agronomy of Gembloux	BE
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Lawrence B. Cohen	2/12/2020	Yale University	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Lawrence B. Cohen	2/12/2020	Yale University	US
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	Axel T Brunger	2/7/2020	Stanford University	US
Anti-Cavbeta1 Ca2+ channel [N7/18.1R]	114497	Axel T Brunger	2/7/2020	Stanford University	US
Anti-VGlut1 [N28/9R]	128638	Axel T Brunger	2/7/2020	Stanford University	US
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Pere Roca-Cusachs	2/7/2020	Institut de Bioenginyeria de Catalunya (IBEC)	ES
HS69 pComb3xss anti-Homer1 nanobody	134716	Thomas Blanpied	1/31/2020	University of Maryland, Baltimore	US
HS38 pEYFPN1 anti-Homer1 nanobody	135221	Thomas Blanpied	1/31/2020	University of Maryland, Baltimore	US
Anti-SynCAM4 [N244/5R]	114562	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-Kv4.2 K+ Channel (External) [K57/1R]	128622	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-HCN1 [N70/28R]	114512	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-Ankyrin-G (staining) [N106/43R]	128635	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Dies Meijer	1/29/2020	University of Edinburgh	GB
Anti-Ankyrin-R [N388A/10R]	114479	Dies Meijer	1/29/2020	University of Edinburgh	GB
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Nathalie Sans	1/28/2020	Delegation INSERM Nouvelle-Aquitaine	FR
Anti-Dopamine D3 receptor [N331/19R]	114488	Peter McCormick	1/23/2020	Barts and The London School of Medicine and Dentistry, Queen Mary, University of London	GB
Anti-GFP [N86/38.1R]	114492	Peter McCormick	1/23/2020	Barts and The London School of Medicine and Dentistry, Queen Mary, University of London	GB
HS38 pEYFPN1 anti-Homer1 nanobody	135221	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
HS22 pEYFPN1 anti-Homer1 nanobody	135219	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
SS80 pEGFPN1 anti-SAPAP2 nanobody	135228	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
AC27 pEGFPN1 anti-AMIGO-1 nanobody	135226	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
AC50 pEGFPN1 anti-AMIGO-1 nanobody	135225	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
IC65 pEGFPN1 anti-IRSp53 nanobody	135227	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Sumio Terada	1/21/2020	Tokyo Medical and Dental University	JP
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Victor Anggono	1/16/2020	University of Queensland	AU
Anti-GFP [N86/38.1R]	114492	Victor Anggono	1/16/2020	University of Queensland	AU
Anti-PSD-95 [K28/43R]	128618	Victor Anggono	1/16/2020	University of Queensland	AU
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Victor Anggono	1/16/2020	University of Queensland	AU
HC87 pEYFPN1 anti-Homer1 nanobody	135223	Victor Anggono	1/16/2020	University of Queensland	AU
GC83 pComb3xss anti-Gephyrin nanobody	134721	Hiroyuki Hioki	1/14/2020	Juntendo University	JP
HS69 pComb3xss anti-Homer1 nanobody	134716	Hiroyuki Hioki	1/14/2020	Juntendo University	JP
GC1 pComb3xss anti-Gephyrin nanobody	134720	Hiroyuki Hioki	1/14/2020	Juntendo University	JP
HS63 pComb3xss anti-Homer1 nanobody	134715	Hiroyuki Hioki	1/14/2020	Juntendo University	JP
Anti-SAP97 [K64/15R]	128624	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-Neuroligin-3 [N110/29.4R]	114518	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-VGlut1 [N28/9R]	128638	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-Ankyrin-G (staining) [N106/43R]	128635	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-Neuroligin-1 [N97A/31R]	114554	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-PSD-95 [K28/43R]	128618	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
Anti-GABA(A)R, Beta1 [N96/55.3R]	114549	Matthew Kennedy	1/13/2020	University of Colorado Denver and Anschutz Medical Campus	US
HC20  pEYFPN1 anti-Homer1 nanobody	135220	Axel T Brunger	1/7/2020	Stanford University	US
GC52 pEGFPN1 anti-Gephyrin nanobody	135224	Axel T Brunger	1/7/2020	Stanford University	US
Anti-GFP [N86/38.1R]	114492	DORON GERBER	12/31/2019	Bar-Ilan University	IL
Anti-GFP [N86/38.1R]	114492	Qunwei Lu	12/31/2019	Huazhong University of Science & Technology	CN
Anti-GFP [N86/38.1R]	114492	Ivo Spiegel	12/29/2019	Weizmann Institute of Science	IL
Anti-Kv2.1 K+ Channel [K89/34R]	128628	Ruth Murrell Lagnado	12/17/2019	University of Sussex	GB
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Ruth Murrell Lagnado	12/17/2019	University of Sussex	GB
HC89 pComb3xss anti-Homer1 nanobody	134719	FLORIN ALBEANU	12/9/2019	Cold Spring Harbor Laboratory	US
HS63 pComb3xss anti-Homer1 nanobody	134715	FLORIN ALBEANU	12/9/2019	Cold Spring Harbor Laboratory	US
GC83 pComb3xss anti-Gephyrin nanobody	134721	FLORIN ALBEANU	12/9/2019	Cold Spring Harbor Laboratory	US
GC1 pComb3xss anti-Gephyrin nanobody	134720	FLORIN ALBEANU	12/9/2019	Cold Spring Harbor Laboratory	US
HS89 pComb3xss anti-Homer1 nanobody	134717	FLORIN ALBEANU	12/9/2019	Cold Spring Harbor Laboratory	US
Anti-GFP [N86/38.1R]	114492	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Navbeta4 Na+ channel [N168/6.3R]	114505	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Ankyrin-G (staining) [N106/43R]	128635	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Ankyrin-R [N388A/10R]	114479	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-WAVE1/SCAR [K91/36R]	128629	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Kv1.4 K+ channel [K13/31R]	128613	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R]	128615	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-KChIP3/DREAM [K66/38R]	128625	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-GFAP R416WT [N206B/9R]	114536	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-SynCAM4 [N244/5R]	114562	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Pan-Kvbeta K+ channel [K25/73R]	128617	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Kv1.1 K+ channel [K20/78R]	128616	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-S100A5 [N176A/35.1R]	114560	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-LRP4 (cytoplasmic) [N164/6.1R]	114542	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Nav1.1 Na+ channel [K74/71R]	128626	Elior Peles	12/5/2019	Weizmann Institute of Science	IL
Anti-Kv1.4 K+ channel [K13/31R]	128613	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-PSD-95 [K28/43R]	128618	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Mortalin/GRP75 [N52A/42.1R]	114548	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Kv1.1 K+ channel (External) [K36/15R]	128619	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Kv1.1 K+ channel [K20/78R]	128616	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Pan-Nav channel [K58/35R]	128623	Dies Meijer	12/3/2019	University of Edinburgh	GB
Anti-Ankyrin-G (staining) [N106/43R]	128635	Pietro Fazzari	12/2/2019	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-VGlut1 [N28/9R]	128638	Pietro Fazzari	12/2/2019	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-PSD-95 [K28/43R]	128618	Pietro Fazzari	12/2/2019	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Pietro Fazzari	12/2/2019	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-GFP [N86/38.1R]	114492	Pietro Fazzari	12/2/2019	Centro de Investigacion Principe Felipe (CIPF)	ES
Anti-Mortalin/GRP75 [N52A/42.1R]	114548	LIUYONG	11/19/2019	Wuhan University	CN
Anti-Mortalin/GRP75 [N52A/42.1R]	114548	Violaine Moreau	11/14/2019	INSERM U1053, Bordeaux Research In Translational Oncology (BaRITOn) INACTIVE	FR
Anti-SynDIG1/Tmem90b [L42/17R]	128632	Eric Gouaux	11/8/2019	Oregon Health & Science University	US
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Masaki Fukata	10/30/2019	National Institute for Physiological Sciences	JP
Anti-SAP97 [K64/15R]	128624	Masaki Fukata	10/30/2019	National Institute for Physiological Sciences	JP
Anti-PSD-95 [K28/43R]	128618	Ann Marie Craig	10/17/2019	University of British Columbia	CA
Anti-Pan-Ankyrin [N388A/60R]	128640	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Kirrel3, short and long [N321C/49R]	114490	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Mitofusin-2 [N153/5.1R]	114547	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Ankyrin-R [N388A/10R]	114479	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Kv1.2 K+ Channel [K14/16R]	128614	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-KChIP3/DREAM [K66/38R]	128625	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-SynDIG1/Tmem90b [L42/17R]	128632	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Kv1.1 K+ channel [K20/78R]	128616	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Pan-Nav channel [K58/35R]	128623	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-GFAP R416WT [N206B/9R]	114536	Battefeld	10/17/2019	University of Bordeaux	FR
K51/1RAnti-SH3GL1/Endophilin A2 [K51/1R]	128621	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Kv1.1 K+ channel (External) [K36/15R]	128619	Battefeld	10/17/2019	University of Bordeaux	FR
Anti-Foxi3 [N359/28R]	114495	Caroline Hill	10/16/2019	Francis Crick Institute	GB
Anti-INPP4b [N171/17.4R]	114551	Ulrich Rothbauer	10/15/2019	Naturwissenschaftliches und Medizinisches Institut an der Universitaet Tuebingen (NMI)	DE
Anti-PSD-95 [K28/43R]	128618	Susumu Tomita	10/8/2019	Yale University	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Susumu Tomita	10/8/2019	Yale University	US
Anti-GFP [N86/38.1R]	114492	Yubin Zhou	10/2/2019	Texas A&M Health Science Center	US
Anti-Pan-Nav1 Na+ channel [N419/40R]	114552	Stephen Brohawn	9/16/2019	University of California, Berkeley	US
Anti-Olig1 [N149/25.1R]	114540	Byungha Oh	9/8/2019	Korea Advanced Institute of Science and Technology	KR
Anti-INPP4b [N171/17.4R]	114551	Leonardo Salmena	8/16/2019	University of Toronto	CA
Anti-GFP [N86/38.1R]	114492	Leonardo Salmena	8/16/2019	University of Toronto	CA
Anti-HCN1 [N70/28R]	114512	Sheila Baker	8/12/2019	University of Iowa	US
Anti-Mitofusin-2 [N153/5.1R]	114547	Sheila Baker	7/29/2019	University of Iowa	US
Anti-Olig1 [N149/25.1R]	114540	Michael Courtney	7/28/2019	Turku Bioscience Centre	FI
Anti-Pan-SAPAP [N127/31.1R]	114529	Michael Courtney	7/28/2019	Turku Bioscience Centre	FI
Anti-GFAP R416WT [N206B/9R]	114536	Howard Chang	7/16/2019	Stanford University	US
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	Emmanuel BOURINET	7/1/2019	CNRS, Delegation Occitanie Est	FR
Anti-Pan-Nav1 Na+ channel [N419/78R]	114553	Battefeld	6/5/2019	University of Bordeaux	FR
Anti-GFP [N86/38.1R]	114492	Battefeld	6/5/2019	University of Bordeaux	FR
Anti-HCN1 [N70/28R]	114512	Battefeld	6/5/2019	University of Bordeaux	FR
Anti-HCN4 [N114/10.1R]	114506	Battefeld	6/5/2019	University of Bordeaux	FR
Anti-Olig1 [N149/25.1R]	114540	Battefeld	6/5/2019	University of Bordeaux	FR
Anti-Mitofusin-2 [N153/5.1R]	114547	Nicolas Touret	4/10/2019	University of Alberta	CA
Anti-NSD3 [N348/82R]	114485	Adriano Aguzzi	4/10/2019	Zurich University Hospital	CH
Anti-INPP4b [N171/17.4R]	114551	Y.Zhang	4/9/2019	Xiamen University	CN
Anti-Mitofusin-2 [N153/5.1R]	114547	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-LRRK1 [N341/37R]	114503	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-Dopamine D3 receptor [N331/19R]	114488	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-Neuroligin-1 [N97A/31R]	114554	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-VGlut2 [N29/29R]	114501	Thierry Galli	3/26/2019	Delegation INSERM Paris 5	FR
Anti-Cav3.1 Ca2+ channel [N178A/9.1R]	114520	David Anderson	3/19/2019	California Institute of Technology	US
Anti-VGlut2 [N29/29R]	114501	David Anderson	3/19/2019	California Institute of Technology	US
Anti-Ataxin-1, 11NQ [N76/3R]	114559	Ray Truant	3/5/2019	McMaster University	CA
Anti-Pan-QKI [N147/6.1R]	114521	Shu-Hsia Chen	2/28/2019	The Methodist Hospital Research Institute	US
Anti-Neuroligin-3 [N110/29.4R]	114518	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-S100A5 [N176A/35.1R]	114560	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-LRRK1 [N341/37R]	114503	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-Ataxin-1, 11NQ [N76/3R]	114559	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-Synaptotagmin-10 [N269/73R]	114558	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-VGlut2 [N29/29R]	114501	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-Cavbeta1 Ca2+ channel [N7/18.1R]	114497	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-KCNU1/Slo3 maxi-K+ channel [N2/16R]	114541	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-GABA(B)R2 [N81/37.1R]	114544	Dr Darren Nesbeth	1/31/2019	University College London	GB
Anti-Kv3.1b K+ channel [N16B/8R]	114511	Stephen Brohawn	12/11/2018	University of California, Berkeley	US
Anti-LRP4 (cytoplasmic) [N164/6.1R]	114542	Jiang Chang	12/8/2018	Texas A&M Health Science Center	US
Anti-LRP4 (cytoplasmic) [N164/6.1R]	114542	Jiang Chang	12/3/2018	Texas A&M Health Science Center	US
Anti-QKI-6 [N182/17.1R]	114561	Gavin Wright	11/28/2018	Wellcome Sanger Institute	GB
Anti-VGlut2 [N29/29R]	114501	George Church	11/26/2018	Harvard Medical School	US
Anti-Neuroligin-3 [N110/29.4R]	114518	George Church	11/26/2018	Harvard Medical School	US
Anti-GluA1/GluR1 glutamate receptor [N355/1R]	114483	George Church	11/26/2018	Harvard Medical School	US
Anti-Cavbeta1 Ca2+ channel [N7/18.1R]	114497	George Church	11/26/2018	Harvard Medical School	US